| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.7 | 0.008 | 0.796 | Aldehyde oxidase inhibitor | 0.796 0.004 CID_7258 0.724 0.007 CID_11334 | CID_7258 | |
| 0.675 | 0.009 | 0.675 | 5 Hydroxytryptamine release stimulant | 0.629 0.012 CID_7258 0.57 0.018 CID_11334 | ||
| 0.667 | 0.004 | 0.667 | GABA C receptor rho-3 antagonist | 0.664 0.004 CID_7258 0.628 0.005 CID_11334 | ||
| 0.633 | 0.007 | 0.633 | 5 Hydroxytryptamine release inhibitor | 0.623 0.008 CID_7258 0.58 0.014 CID_11334 | ||
| 0.545 | 0.018 | 0.545 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.416 0.087 CID_7258 0.419 0.085 CID_11334 | ||
| 0.527 | 0.004 | 0.527 | 5 Hydroxytryptamine uptake stimulant | 0.492 0.005 CID_7258 0.495 0.005 CID_11334 | ||
| 0.519 | 0.008 | 0.631 | Peroxidase inhibitor | 0.63 0.004 CID_7258 0.631 0.004 CID_11334 | CID_11334 | |
| 0.537 | 0.039 | 0.537 | Analgesic | 0.436 0.07 CID_7258 0.26 0.174 CID_11334 | ||
| 0.526 | 0.029 | 0.56 | Cholesterol antagonist | 0.56 0.024 CID_7258 0.508 0.031 CID_11334 | CID_7258 | |
| 0.464 | 0.006 | 0.464 | Alpha-N-acetylglucosaminidase inhibitor | 0.375 0.01 CID_7258 0.335 0.013 CID_11334 | ||
| 0.499 | 0.06 | 0.56 | Caspase 9 stimulant | 0.526 0.051 CID_7258 0.56 0.043 CID_11334 | CID_11334 | |
| 0.43 | 0.015 | 0.43 | Calcium channel activator | 0.389 0.029 CID_7258 0.372 0.037 CID_11334 | ||
| 0.425 | 0.018 | 0.425 | Sigma receptor agonist | 0.252 0.048 CID_7258 0.149 0.085 CID_11334 | ||
| 0.45 | 0.05 | 0.466 | Histamine release inhibitor | 0.466 0.042 CID_7258 0.429 0.061 CID_11334 | CID_7258 | |
| 0.413 | 0.025 | 0.439 | Superoxide dismutase inhibitor | 0.439 0.02 CID_7258 0.386 0.029 CID_11334 | CID_7258 | |
| 0.389 | 0.005 | 0.389 | Chemokine receptor antagonist | 0.183 0.022 CID_7258 0.099 0.064 CID_11334 | ||
| 0.4 | 0.016 | 0.4 | Anesthetic general | 0.376 0.02 CID_7258 0.345 0.025 CID_11334 | ||
| 0.389 | 0.009 | 0.453 | Tyrosine 3 hydroxylase inhibitor | 0.453 0.005 CID_7258 0.401 0.008 CID_11334 | CID_7258 | |
| 0.383 | 0.005 | 0.383 | GABA C receptor agonist | 0.327 0.008 CID_7258 0.287 0.01 CID_11334 | ||
| 0.382 | 0.004 | 0.382 | Succinate dehydrogenase inhibitor | 0.382 0.004 CID_7258 0.375 0.005 CID_11334 | ||
| 0.381 | 0.005 | 0.558 | Cystathionine beta-synthase inhibitor | 0.558 0.003 CID_7258 0.555 0.003 CID_11334 | CID_7258 | |
| 0.379 | 0.004 | 0.379 | Ferrochelatase inhibitor | 0.246 0.014 CID_7258 0.225 0.017 CID_11334 | ||
| 0.37 | 0.004 | 0.37 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.358 0.004 CID_7258 0.286 0.007 CID_11334 | ||
| 0.402 | 0.037 | 0.402 | Aryl hydrocarbon receptor agonist | 0.341 0.05 CID_7258 0.294 0.063 CID_11334 | ||
| 0.358 | 0.008 | 0.4 | UDP-glucose 4-epimerase inhibitor | 0.4 0.006 CID_7258 0.336 0.009 CID_11334 | CID_7258 | |
| 0.347 | 0.005 | 0.347 | CC chemokine receptor antagonist | 0.132 0.022 CID_7258 0.068 0.066 CID_11334 | ||
| 0.347 | 0.005 | 0.347 | 5 Hydroxytryptamine uptake inhibitor | 0.115 0.022 CID_7258 0.128 0.019 CID_11334 | ||
| 0.4 | 0.061 | 0.4 | Calpain 2 inhibitor | 0.339 0.092 CID_7258 0.253 0.148 CID_11334 | ||
| 0.37 | 0.032 | 0.37 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.352 | 0.024 | 0.352 | RNA-directed DNA polymerase inhibitor | 0.344 0.025 CID_7258 0.291 0.033 CID_11334 | ||
| 0.334 | 0.006 | 0.343 | Nitric-oxide synthase stimulant | 0.343 0.005 CID_7258 0.308 0.009 CID_11334 | CID_7258 | |
| 0.327 | 0.003 | 0.327 | CC chemokine receptor 2B antagonist | 0.084 0.008 CID_7258 0.066 0.014 CID_11334 | ||
| 0.375 | 0.054 | 0.389 | Streptokinase A inhibitor | 0.384 0.051 CID_7258 0.389 0.05 CID_11334 | CID_11334 | |
| 0.321 | 0.004 | 0.321 | Electrolyte absorption antagonist | 0.266 0.004 CID_7258 0.276 0.004 CID_11334 | ||
| 0.329 | 0.016 | 0.329 | 5 Hydroxytryptamine 1E antagonist | 0.305 0.026 CID_7258 0.284 0.041 CID_11334 | ||
| 0.31 | 0.004 | 0.31 | Adrenaline uptake inhibitor | 0.147 0.009 CID_7258 0.179 0.007 CID_11334 | ||
| 0.307 | 0.004 | 0.307 | Potassium channel large-conductance Ca-activated activator | 0.298 0.004 CID_7258 0.204 0.006 CID_11334 | ||
| 0.306 | 0.005 | 0.306 | GABA C receptor rho-2 antagonist | 0.269 0.009 CID_7258 0.241 0.014 CID_11334 | ||
| 0.301 | 0.005 | 0.318 | Mannose-6-phosphate isomerase inhibitor | 0.301 0.005 CID_7258 0.318 0.005 CID_11334 | CID_11334 | |
| 0.359 | 0.07 | 0.359 | Vasodilator, peripheral | 0.356 0.071 CID_7258 0.257 0.122 CID_11334 | ||
| 0.293 | 0.005 | 0.293 | 5 Hydroxytryptamine 3E antagonist | 0.224 0.032 CID_7258 0.226 0.03 CID_11334 | ||
| 0.299 | 0.011 | 0.299 | 3C-like protease (Human coronavirus) inhibitor | 0.279 0.017 CID_7258 0.212 0.045 CID_11334 | ||
| 0.323 | 0.037 | 0.323 | Psychostimulant | 0.287 0.046 CID_7258 0.201 0.079 CID_11334 | ||
| 0.288 | 0.007 | 0.298 | ATPase inhibitor | 0.298 0.006 CID_7258 0.244 0.015 CID_11334 | CID_7258 | |
| 0.36 | 0.082 | 0.36 | Antiobesity | 0.254 0.152 CID_7258 | ||
| 0.281 | 0.004 | 0.281 | Glutamate release inhibitor | 0.223 0.004 CID_7258 0.204 0.005 CID_11334 | ||
| 0.331 | 0.055 | 0.392 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.303 0.063 CID_7258 0.392 0.04 CID_11334 | CID_11334 | |
| 0.337 | 0.062 | 0.339 | Vasodilator, coronary | 0.313 0.077 CID_7258 0.339 0.061 CID_11334 | CID_11334 | |
| 0.275 | 0.005 | 0.402 | Creatine kinase inhibitor | 0.402 0.003 CID_7258 0.328 0.004 CID_11334 | CID_7258 | |
| 0.274 | 0.005 | 0.274 | EphA2 antagonist | 0.155 0.028 CID_7258 0.158 0.027 CID_11334 | ||
| 0.272 | 0.005 | 0.272 | GABA C receptor antagonist | 0.235 0.008 CID_7258 0.203 0.012 CID_11334 | ||
| 0.266 | 0.004 | 0.266 | 5 Hydroxytryptamine 3A agonist | 0.23 0.008 CID_7258 0.201 0.015 CID_11334 | ||
| 0.296 | 0.035 | 0.296 | Gastrin inhibitor | 0.224 0.114 CID_7258 0.219 0.12 CID_11334 | ||
| 0.274 | 0.013 | 0.274 | Glutamate receptor antagonist | 0.19 0.029 CID_7258 0.187 0.03 CID_11334 | ||
| 0.265 | 0.005 | 0.265 | Purinergic P2 antagonist | |||
| 0.265 | 0.007 | 0.265 | NADH dehydrogenase inhibitor | 0.261 0.007 CID_7258 0.23 0.009 CID_11334 | ||
| 0.26 | 0.007 | 0.33 | Potassium channel (Ca-activated) activator | 0.33 0.005 CID_7258 0.256 0.007 CID_11334 | CID_7258 | |
| 0.275 | 0.022 | 0.351 | Amylase inhibitor | 0.351 0.013 CID_7258 0.282 0.021 CID_11334 | CID_7258 | |
| 0.282 | 0.029 | 0.282 | Neuropeptide Y2 antagonist | 0.266 0.042 CID_7258 0.244 0.062 CID_11334 | ||
| 0.257 | 0.005 | 0.257 | HIV-1 integrase (Overall Integration) inhibitor | 0.248 0.005 CID_7258 0.253 0.005 CID_11334 | ||
| 0.298 | 0.049 | 0.298 | Interleukin agonist | 0.262 0.07 CID_7258 0.244 0.083 CID_11334 | ||
| 0.275 | 0.026 | 0.31 | Neurotrophic factor enhancer | 0.31 0.015 CID_7258 0.279 0.025 CID_11334 | CID_7258 | |
| 0.279 | 0.031 | 0.304 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.304 0.022 CID_7258 0.272 0.033 CID_11334 | CID_7258 | |
| 0.251 | 0.005 | 0.251 | Dopamine D4 agonist | 0.051 0.034 CID_7258 | ||
| 0.288 | 0.048 | 0.317 | DNA synthesis inhibitor | 0.317 0.038 CID_7258 0.29 0.047 CID_11334 | CID_7258 | |
| 0.251 | 0.012 | 0.295 | Carbonic anhydrase XV inhibitor | 0.295 0.008 CID_7258 0.229 0.014 CID_11334 | CID_7258 | |
| 0.253 | 0.016 | 0.253 | Hexokinase inhibitor | 0.252 0.017 CID_7258 0.223 0.024 CID_11334 | ||
| 0.24 | 0.007 | 0.24 | Triose-phosphate isomerase inhibitor | 0.197 0.011 CID_7258 0.188 0.012 CID_11334 | ||
| 0.291 | 0.061 | 0.347 | Transcription factor STAT inhibitor | 0.335 0.04 CID_7258 0.347 0.035 CID_11334 | CID_11334 | |
| 0.282 | 0.053 | 0.282 | Potassium channel blocker | |||
| 0.292 | 0.063 | 0.292 | Insulysin inhibitor | 0.285 0.068 CID_7258 0.253 0.093 CID_11334 | ||
| 0.305 | 0.077 | 0.416 | 12-Lipoxygenase inhibitor | 0.416 0.035 CID_7258 0.411 0.036 CID_11334 | CID_7258 | |
| 0.243 | 0.016 | 0.243 | Ephrin antagonist | 0.097 0.066 CID_7258 0.103 0.06 CID_11334 | ||
| 0.275 | 0.052 | 0.275 | Cyclic AMP phosphodiesterase inhibitor | 0.24 0.069 CID_7258 0.19 0.102 CID_11334 | ||
| 0.225 | 0.005 | 0.225 | GABA C receptor rho-1 antagonist | 0.185 0.011 CID_7258 0.16 0.017 CID_11334 | ||
| 0.276 | 0.056 | 0.276 | HERG channel blocker | |||
| 0.242 | 0.023 | 0.255 | NADPH oxidase inhibitor | 0.255 0.02 CID_7258 0.197 0.035 CID_11334 | CID_7258 | |
| 0.265 | 0.047 | 0.265 | MAP kinase kinase 2 inhibitor | 0.215 0.072 CID_7258 0.171 0.103 CID_11334 | ||
| 0.281 | 0.063 | 0.321 | Transcription factor STAT3 inhibitor | 0.321 0.044 CID_7258 0.228 0.103 CID_11334 | CID_7258 | |
| 0.221 | 0.004 | 0.221 | Purinergic P2X antagonist | |||
| 0.246 | 0.029 | 0.319 | Interferon gamma antagonist | 0.319 0.017 CID_7258 0.241 0.03 CID_11334 | CID_7258 | |
| 0.22 | 0.004 | 0.22 | Lanosterol 14 alpha demethylase inhibitor | 0.19 0.005 CID_7258 0.17 0.007 CID_11334 | ||
| 0.267 | 0.051 | 0.267 | Anticonvulsant | 0.147 0.133 CID_7258 0.144 0.136 CID_11334 | ||
| 0.241 | 0.027 | 0.376 | Phospholipase C inhibitor | 0.376 0.012 CID_7258 0.231 0.03 CID_11334 | CID_7258 | |
| 0.234 | 0.02 | 0.266 | Cholesterol synthesis inhibitor | 0.266 0.015 CID_7258 0.223 0.022 CID_11334 | CID_7258 | |
| 0.227 | 0.013 | 0.23 | Arachidonic acid antagonist | 0.23 0.012 CID_7258 0.227 0.013 CID_11334 | CID_7258 | |
| 0.258 | 0.048 | 0.258 | ErbB-1 antagonist | 0.21 0.079 CID_7258 0.174 0.125 CID_11334 | ||
| 0.217 | 0.009 | 0.217 | Interleukin 8 antagonist | 0.206 0.011 CID_7258 0.187 0.016 CID_11334 | ||
| 0.228 | 0.022 | 0.315 | Aldehyde dehydrogenase inhibitor | 0.315 0.01 CID_7258 0.205 0.026 CID_11334 | CID_7258 | |
| 0.226 | 0.026 | 0.315 | M18 aspartyl aminopeptidase inhibitor | 0.315 0.011 CID_7258 0.249 0.021 CID_11334 | CID_7258 | |
| 0.244 | 0.045 | 0.244 | Non-steroidal antiinflammatory agent | 0.228 0.053 CID_7258 0.189 0.08 CID_11334 | ||
| 0.205 | 0.008 | 0.205 | Sphingosine 1-phosphate receptor 4 antagonist | 0.17 0.019 CID_7258 0.19 0.011 CID_11334 | ||
| 0.256 | 0.059 | 0.256 | Calpain inhibitor | 0.235 0.08 CID_7258 0.204 0.11 CID_11334 | ||
| 0.317 | 0.12 | 0.405 | 15-Lipoxygenase inhibitor | 0.402 0.074 CID_7258 0.405 0.072 CID_11334 | CID_11334 | |
| 0.202 | 0.008 | 0.202 | Protein kinase B gamma inhibitor | 0.069 0.059 CID_11334 | ||
| 0.202 | 0.01 | 0.202 | Pregnane X receptor agonist | 0.179 0.019 CID_7258 0.171 0.025 CID_11334 | ||
| 0.227 | 0.036 | 0.227 | Cytidine deaminase inhibitor | 0.157 0.07 CID_7258 0.188 0.053 CID_11334 | ||
| 0.226 | 0.036 | 0.263 | Diuretic | 0.199 0.045 CID_7258 0.263 0.029 CID_11334 | CID_11334 | |
| 0.206 | 0.016 | 0.21 | Cyclooxygenase 3 inhibitor | 0.21 0.015 CID_7258 0.192 0.021 CID_11334 | CID_7258 | |
| 0.202 | 0.012 | 0.226 | Porphobilinogen synthase inhibitor | 0.226 0.009 CID_7258 0.212 0.011 CID_11334 | CID_7258 | |
| 0.193 | 0.004 | 0.193 | Ca2+-transporting ATPase inhibitor | 0.187 0.005 CID_7258 0.185 0.005 CID_11334 | ||
| 0.216 | 0.029 | 0.216 | Nav1.2 sodium channel blocker | 0.154 0.055 CID_7258 0.122 0.081 CID_11334 | ||
| 0.227 | 0.042 | 0.296 | Amyloid beta precursor protein antagonist | 0.254 0.031 CID_7258 0.296 0.018 CID_11334 | CID_11334 | |
| 0.198 | 0.013 | 0.296 | Histidine decarboxylase inhibitor | 0.296 0.006 CID_7258 0.211 0.012 CID_11334 | CID_7258 | |
| 0.235 | 0.053 | 0.235 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.168 0.103 CID_7258 | ||
| 0.194 | 0.012 | 0.194 | Sphingosine 1-phosphate receptor 2 agonist | 0.122 0.051 CID_7258 0.107 0.081 CID_11334 | ||
| 0.209 | 0.027 | 0.224 | Cell wall synthesis inhibitor | 0.224 0.022 CID_7258 0.202 0.029 CID_11334 | CID_7258 | |
| 0.197 | 0.015 | 0.197 | Adenylate kinase inhibitor | 0.156 0.024 CID_7258 0.147 0.027 CID_11334 | ||
| 0.202 | 0.021 | 0.218 | CF transmembrane conductance regulator agonist | 0.218 0.014 CID_7258 0.192 0.027 CID_11334 | CID_7258 | |
| 0.244 | 0.063 | 0.28 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.28 0.047 CID_11334 | CID_11334 | |
| 0.185 | 0.007 | 0.356 | Alcohol oxidase inhibitor | 0.356 0.004 CID_7258 0.199 0.007 CID_11334 | CID_7258 | |
| 0.205 | 0.028 | 0.216 | Catenin beta inhibitor | 0.216 0.022 CID_7258 0.171 0.064 CID_11334 | CID_7258 | |
| 0.181 | 0.005 | 0.181 | Dopamine transporter inhibitor | 0.087 0.015 CID_7258 0.115 0.009 CID_11334 | ||
| 0.198 | 0.023 | 0.198 | Cathepsin H inhibitor | 0.15 0.046 CID_7258 0.142 0.053 CID_11334 | ||
| 0.19 | 0.017 | 0.19 | Catalase inhibitor | 0.164 0.023 CID_7258 0.138 0.029 CID_11334 | ||
| 0.23 | 0.059 | 0.23 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.143 0.137 CID_7258 0.184 0.09 CID_11334 | ||
| 0.193 | 0.022 | 0.193 | Nav1.6 sodium channel blocker | 0.144 0.061 CID_7258 0.13 0.081 CID_11334 | ||
| 0.173 | 0.004 | 0.173 | Purinergic P2X7 antagonist | |||
| 0.174 | 0.005 | 0.174 | Potassium channel Kv1.5 blocker | |||
| 0.172 | 0.004 | 0.216 | D-Ala-D-Ala ligase inhibitor | 0.216 0.003 CID_7258 0.195 0.003 CID_11334 | CID_7258 | |
| 0.186 | 0.019 | 0.186 | Sphingosine 1-phosphate receptor 5 antagonist | 0.186 0.019 CID_7258 0.167 0.037 CID_11334 | ||
| 0.18 | 0.012 | 0.184 | Heat shock protein 70 antagonist | 0.184 0.01 CID_7258 0.169 0.018 CID_11334 | CID_7258 | |
| 0.178 | 0.011 | 0.232 | DOPA decarboxylase inhibitor | 0.232 0.004 CID_7258 0.196 0.007 CID_11334 | CID_7258 | |
| 0.172 | 0.006 | 0.172 | NMDA receptor agonist | 0.13 0.011 CID_7258 0.122 0.013 CID_11334 | ||
| 0.276 | 0.109 | 0.383 | Transcription factor NF kappa B inhibitor | 0.357 0.075 CID_7258 0.383 0.067 CID_11334 | CID_11334 | |
| 0.174 | 0.008 | 0.174 | Histamine N-methyltransferase inhibitor | 0.152 0.014 CID_7258 0.137 0.019 CID_11334 | ||
| 0.169 | 0.005 | 0.169 | Neurokinin 2 antagonist | |||
| 0.175 | 0.011 | 0.175 | CYP2A6 inhibitor | 0.093 0.039 CID_7258 0.078 0.05 CID_11334 | ||
| 0.186 | 0.021 | 0.198 | Adenylate cyclase stimulant | 0.198 0.014 CID_7258 0.185 0.022 CID_11334 | CID_7258 | |
| 0.171 | 0.007 | 0.171 | Glutamate (mGluR7) agonist | 0.112 0.039 CID_7258 0.114 0.037 CID_11334 | ||
| 0.19 | 0.028 | 0.19 | Nav1.3 sodium channel blocker | 0.146 0.051 CID_7258 0.101 0.096 CID_11334 | ||
| 0.178 | 0.016 | 0.18 | Sphingosine 1-phosphate receptor 2 antagonist | 0.18 0.015 CID_7258 0.156 0.033 CID_11334 | CID_7258 | |
| 0.162 | 0.004 | 0.162 | Potassium channel intermediate-conductance Ca-activated blocker | 0.067 0.03 CID_7258 0.071 0.026 CID_11334 | ||
| 0.175 | 0.018 | 0.236 | NMDA receptor antagonist | 0.236 0.01 CID_7258 0.194 0.015 CID_11334 | CID_7258 | |
| 0.16 | 0.005 | 0.16 | Aryl hydrocarbon receptor antagonist | 0.12 0.008 CID_7258 0.104 0.012 CID_11334 | ||
| 0.158 | 0.003 | 0.158 | Exportin-1 inhibitor | 0.119 0.005 CID_7258 0.098 0.01 CID_11334 | ||
| 0.188 | 0.034 | 0.188 | Sodium channel (voltage-gated) blocker | 0.142 0.061 CID_7258 | ||
| 0.193 | 0.039 | 0.21 | Neurotensin receptor agonist | 0.21 0.03 CID_7258 0.185 0.045 CID_11334 | CID_7258 | |
| 0.162 | 0.01 | 0.226 | Phenylalanine 4-hydroxylase inhibitor | 0.226 0.005 CID_7258 0.191 0.007 CID_11334 | CID_7258 | |
| 0.184 | 0.032 | 0.184 | MAP kinase 3 inhibitor | 0.145 0.076 CID_7258 0.141 0.082 CID_11334 | ||
| 0.168 | 0.016 | 0.213 | Urease inhibitor | 0.195 0.011 CID_7258 0.213 0.009 CID_11334 | CID_11334 | |
| 0.17 | 0.018 | 0.17 | Calcium antagonist | 0.072 0.071 CID_7258 0.076 0.067 CID_11334 | ||
| 0.265 | 0.114 | 0.274 | Antithrombotic | 0.274 0.108 CID_7258 0.213 0.162 CID_11334 | CID_7258 | |
| 0.173 | 0.022 | 0.24 | Carbonic anhydrase III inhibitor | 0.24 0.01 CID_7258 0.188 0.018 CID_11334 | CID_7258 | |
| 0.155 | 0.004 | 0.155 | NMDA receptor glycine site agonist | 0.124 0.008 CID_7258 0.124 0.008 CID_11334 | ||
| 0.171 | 0.021 | 0.171 | Falcipain 2 inhibitor | 0.085 0.064 CID_7258 | ||
| 0.173 | 0.022 | 0.173 | Falcipain inhibitor | 0.087 0.066 CID_7258 | ||
| 0.168 | 0.018 | 0.168 | Sphingomyelinase inhibitor | 0.151 0.024 CID_7258 0.129 0.035 CID_11334 | ||
| 0.187 | 0.038 | 0.239 | Alkaline phosphatase inhibitor | 0.239 0.022 CID_7258 0.179 0.043 CID_11334 | CID_7258 | |
| 0.266 | 0.119 | 0.406 | Prostaglandin dehydrogenase inhibitor | 0.336 0.088 CID_7258 0.406 0.065 CID_11334 | CID_11334 | |
| 0.154 | 0.007 | 0.154 | Glycine receptor antagonist | 0.122 0.017 CID_7258 0.122 0.017 CID_11334 | ||
| 0.19 | 0.043 | 0.19 | Thiol protease inhibitor | 0.144 0.075 CID_7258 0.13 0.096 CID_11334 | ||
| 0.159 | 0.012 | 0.159 | Nav1.8 sodium channel blocker | 0.158 0.013 CID_7258 | ||
| 0.197 | 0.051 | 0.215 | Antipruritic | 0.215 0.039 CID_7258 | CID_7258 | |
| 0.197 | 0.051 | 0.337 | Heat shock protein 90 alpha antagonist | 0.298 0.015 CID_7258 0.337 0.01 CID_11334 | CID_11334 | |
| 0.161 | 0.016 | 0.174 | Transcription factor STAT6 inhibitor | 0.174 0.012 CID_7258 0.164 0.015 CID_11334 | CID_7258 | |
| 0.205 | 0.061 | 0.205 | Histone acetyltransferase inhibitor | 0.184 0.094 CID_7258 0.149 0.141 CID_11334 | ||
| 0.176 | 0.033 | 0.181 | Neuropeptide Y1 antagonist | 0.181 0.029 CID_7258 0.149 0.067 CID_11334 | CID_7258 | |
| 0.208 | 0.065 | 0.262 | DNA methyltransferase I inhibitor | 0.262 0.042 CID_7258 0.248 0.048 CID_11334 | CID_7258 | |
| 0.163 | 0.02 | 0.216 | Beta glucuronidase inhibitor | 0.216 0.011 CID_7258 0.171 0.018 CID_11334 | CID_7258 | |
| 0.151 | 0.009 | 0.151 | Bromodomain-containing protein 2 inhibitor | 0.104 0.035 CID_7258 0.092 0.052 CID_11334 | ||
| 0.233 | 0.091 | 0.233 | DNA damaging | 0.221 0.099 CID_7258 | ||
| 0.164 | 0.023 | 0.164 | TRPA1 agonist | 0.162 0.023 CID_7258 0.141 0.038 CID_11334 | ||
| 0.149 | 0.008 | 0.162 | GABA aminotransferase inhibitor | 0.162 0.006 CID_7258 0.135 0.011 CID_11334 | CID_7258 | |
| 0.202 | 0.062 | 0.202 | LIM domain kinase 1 inhibitor | 0.184 0.071 CID_7258 | ||
| 0.146 | 0.006 | 0.19 | NMDA receptor subunit 3B antagonist | 0.19 0.005 CID_7258 0.19 0.005 CID_11334 | CID_11334 | |
| 0.286 | 0.146 | 0.349 | Antibacterial | 0.345 0.105 CID_7258 0.349 0.103 CID_11334 | CID_11334 | |
| 0.15 | 0.011 | 0.15 | Carbamoyl phosphate synthetase inhibitor | 0.128 0.014 CID_7258 0.115 0.017 CID_11334 | ||
| 0.157 | 0.018 | 0.157 | Potassium channel activator | 0.118 0.034 CID_7258 0.096 0.052 CID_11334 | ||
| 0.153 | 0.014 | 0.153 | Acetylcholine release stimulant | 0.111 0.065 CID_7258 0.107 0.071 CID_11334 | ||
| 0.25 | 0.112 | 0.455 | Caspase 3 stimulant | 0.402 0.044 CID_7258 0.455 0.028 CID_11334 | CID_11334 | |
| 0.192 | 0.054 | 0.192 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.168 | 0.03 | 0.168 | Aminopeptidase B inhibitor | 0.155 0.036 CID_7258 0.14 0.042 CID_11334 | ||
| 0.147 | 0.009 | 0.15 | Sphingosine 1-phosphate receptor 4 agonist | 0.15 0.008 CID_7258 0.106 0.022 CID_11334 | CID_7258 | |
| 0.145 | 0.008 | 0.145 | Glycine receptor agonist | 0.127 0.011 CID_7258 0.125 0.011 CID_11334 | ||
| 0.151 | 0.014 | 0.151 | Cannabinoid receptor antagonist | 0.082 0.039 CID_7258 | ||
| 0.159 | 0.023 | 0.207 | AMP-activated protein kinase stimulant | 0.207 0.01 CID_7258 0.144 0.032 CID_11334 | CID_7258 | |
| 0.14 | 0.004 | 0.14 | Glutamate (mGluR6) antagonist | 0.11 0.007 CID_7258 0.108 0.008 CID_11334 | ||
| 0.144 | 0.009 | 0.144 | Prostaglandin E2 antagonist | 0.053 0.033 CID_7258 | ||
| 0.151 | 0.018 | 0.151 | Phosphofructokinase-1 inhibitor | 0.15 0.018 CID_7258 0.134 0.021 CID_11334 | ||
| 0.184 | 0.051 | 0.184 | Interleukin 6 antagonist | 0.163 0.072 CID_7258 | ||
| 0.207 | 0.075 | 0.241 | DNA methylase inhibitor | 0.241 0.053 CID_7258 0.234 0.058 CID_11334 | CID_7258 | |
| 0.142 | 0.01 | 0.142 | Biliverdin reductase inhibitor | 0.095 0.02 CID_7258 0.082 0.025 CID_11334 | ||
| 0.148 | 0.016 | 0.148 | Glutamate dehydrogenase inhibitor | 0.129 0.02 CID_7258 0.12 0.023 CID_11334 | ||
| 0.155 | 0.024 | 0.155 | Nav1.5 sodium channel blocker | 0.13 0.043 CID_7258 | ||
| 0.135 | 0.005 | 0.156 | GABA B receptor agonist | 0.156 0.004 CID_7258 0.131 0.005 CID_11334 | CID_7258 | |
| 0.147 | 0.017 | 0.16 | MAP kinase kinase 1 inhibitor | 0.16 0.013 CID_7258 0.142 0.02 CID_11334 | CID_7258 | |
| 0.173 | 0.044 | 0.173 | Sodium channel blocker | 0.131 0.073 CID_7258 | ||
| 0.146 | 0.017 | 0.199 | NMDA 2 receptor antagonist | 0.199 0.009 CID_7258 0.116 0.025 CID_11334 | CID_7258 | |
| 0.133 | 0.004 | 0.133 | Phospholipase D inhibitor | 0.1 0.015 CID_7258 0.096 0.017 CID_11334 | ||
| 0.132 | 0.004 | 0.132 | Vanilloid 4 agonist | 0.102 0.015 CID_7258 0.103 0.015 CID_11334 | ||
| 0.228 | 0.101 | 0.233 | Spasmolytic | 0.23 0.1 CID_7258 0.233 0.099 CID_11334 | CID_11334 | |
| 0.204 | 0.079 | 0.297 | Pyruvate kinase inhibitor | 0.288 0.051 CID_7258 0.297 0.048 CID_11334 | CID_11334 | |
| 0.147 | 0.021 | 0.2 | Carbonic anhydrase VI inhibitor | 0.2 0.013 CID_7258 0.145 0.022 CID_11334 | CID_7258 | |
| 0.133 | 0.009 | 0.133 | Cannabinoid CB1 receptor antagonist | 0.079 0.027 CID_7258 0.055 0.052 CID_11334 | ||
| 0.144 | 0.021 | 0.154 | Anabolic | 0.154 0.016 CID_7258 0.142 0.023 CID_11334 | CID_7258 | |
| 0.148 | 0.025 | 0.148 | CC chemokine 6 receptor antagonist | 0.146 0.028 CID_7258 0.144 0.032 CID_11334 | ||
| 0.175 | 0.053 | 0.269 | NOS3 expression enhancer | 0.269 0.023 CID_7258 0.149 0.073 CID_11334 | CID_7258 | |
| 0.144 | 0.021 | 0.338 | Interleukin 2 antagonist | 0.338 0.004 CID_11334 | CID_11334 | |
| 0.127 | 0.005 | 0.127 | Nicotinic alpha3beta2 receptor antagonist | 0.088 0.01 CID_7258 0.075 0.015 CID_11334 | ||
| 0.235 | 0.114 | 0.319 | Hypoxia-inducible factor 1 alpha inhibitor | 0.319 0.057 CID_7258 0.261 0.091 CID_11334 | CID_7258 | |
| 0.133 | 0.012 | 0.133 | Dopamine uptake inhibitor | 0.106 0.017 CID_7258 0.095 0.02 CID_11334 | ||
| 0.132 | 0.012 | 0.132 | Nicotinic alpha4beta2 receptor antagonist | 0.1 0.031 CID_7258 0.075 0.055 CID_11334 | ||
| 0.133 | 0.016 | 0.133 | Prostaglandin-E synthase inhibitor | 0.12 0.019 CID_7258 0.082 0.038 CID_11334 | ||
| 0.127 | 0.01 | 0.153 | Purinergic P2X1 antagonist | 0.153 0.007 CID_7258 0.13 0.01 CID_11334 | CID_7258 | |
| 0.125 | 0.008 | 0.125 | 5 Hydroxytryptamine 2A agonist | 0.124 0.009 CID_7258 0.085 0.023 CID_11334 | ||
| 0.141 | 0.025 | 0.141 | Phosphodiesterase 7B inhibitor | |||
| 0.12 | 0.004 | 0.12 | Potassium channel small-conductance Ca-activated activator | 0.037 0.017 CID_7258 0.036 0.017 CID_11334 | ||
| 0.127 | 0.012 | 0.127 | Acyl-CoA dehydrogenase inhibitor | 0.084 0.021 CID_7258 0.073 0.025 CID_11334 | ||
| 0.129 | 0.014 | 0.129 | ATPase (Vacuolar H+) inhibitor | 0.113 0.025 CID_7258 0.112 0.026 CID_11334 | ||
| 0.151 | 0.036 | 0.151 | Falcipain 3 inhibitor | 0.113 0.059 CID_7258 0.097 0.074 CID_11334 | ||
| 0.119 | 0.005 | 0.119 | Dopamine D3 agonist | 0.073 0.01 CID_7258 0.062 0.013 CID_11334 | ||
| 0.12 | 0.006 | 0.12 | Aconitate hydratase inhibitor | 0.081 0.013 CID_7258 0.08 0.014 CID_11334 | ||
| 0.131 | 0.017 | 0.171 | Glutamate decarboxylase inhibitor | 0.171 0.01 CID_7258 0.136 0.016 CID_11334 | CID_7258 | |
| 0.14 | 0.027 | 0.155 | Prolactin inhibitor | 0.155 0.02 CID_7258 0.129 0.032 CID_11334 | CID_7258 | |
| 0.117 | 0.004 | 0.117 | MDM2 inhibitor | 0.103 0.006 CID_7258 0.1 0.007 CID_11334 | ||
| 0.17 | 0.057 | 0.17 | Cyclooxygenase inhibitor | 0.169 0.057 CID_7258 0.112 0.109 CID_11334 | ||
| 0.168 | 0.056 | 0.196 | Protein kinase stimulant | 0.196 0.043 CID_7258 0.154 0.066 CID_11334 | CID_7258 | |
| 0.125 | 0.013 | 0.125 | Granulocyte macrophage colony stimulating factor agonist | 0.113 0.021 CID_7258 0.114 0.02 CID_11334 | ||
| 0.171 | 0.06 | 0.171 | Cyclin-dependent kinase 8 inhibitor | 0.122 0.115 CID_7258 0.133 0.099 CID_11334 | ||
| 0.118 | 0.007 | 0.149 | NMDA receptor subunit 3A antagonist | 0.149 0.005 CID_7258 0.142 0.005 CID_11334 | CID_7258 | |
| 0.114 | 0.004 | 0.114 | CC chemokine 4 receptor antagonist | 0.07 0.01 CID_7258 0.06 0.016 CID_11334 | ||
| 0.153 | 0.043 | 0.153 | Antibacterial (Helicobacter pylori) | 0.127 0.071 CID_7258 0.109 0.1 CID_11334 | ||
| 0.114 | 0.005 | 0.114 | Glutamate (mGluR7) antagonist | 0.099 0.011 CID_7258 0.094 0.015 CID_11334 | ||
| 0.119 | 0.011 | 0.122 | NMDA 2C receptor antagonist | 0.122 0.01 CID_7258 0.096 0.017 CID_11334 | CID_7258 | |
| 0.134 | 0.025 | 0.178 | Carbonic anhydrase XIII inhibitor | 0.178 0.017 CID_7258 0.122 0.029 CID_11334 | CID_7258 | |
| 0.113 | 0.004 | 0.113 | Calcium channel P-type blocker | 0.081 0.014 CID_7258 0.083 0.013 CID_11334 | ||
| 0.162 | 0.055 | 0.205 | MAO inhibitor | 0.205 0.039 CID_7258 0.194 0.043 CID_11334 | CID_7258 | |
| 0.148 | 0.042 | 0.148 | Beta amyloid protein antagonist | 0.13 0.057 CID_7258 | ||
| 0.116 | 0.01 | 0.116 | 5 Hydroxytryptamine 3 agonist | 0.079 0.027 CID_7258 0.067 0.039 CID_11334 | ||
| 0.167 | 0.062 | 0.228 | Melanin inhibitor | 0.228 0.033 CID_7258 0.184 0.049 CID_11334 | CID_7258 | |
| 0.119 | 0.015 | 0.119 | T cell inhibitor | 0.096 0.028 CID_11334 | ||
| 0.121 | 0.017 | 0.121 | mTOR complex 2 inhibitor | 0.103 0.029 CID_7258 0.096 0.038 CID_11334 | ||
| 0.108 | 0.004 | 0.108 | Potassium channel (Inward rectifier) activator | 0.073 0.01 CID_7258 0.068 0.013 CID_11334 | ||
| 0.108 | 0.004 | 0.108 | Glutamate (mGluR3) antagonist | 0.077 0.005 CID_7258 0.068 0.006 CID_11334 | ||
| 0.111 | 0.008 | 0.111 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.082 0.034 CID_7258 0.083 0.032 CID_11334 | ||
| 0.12 | 0.017 | 0.12 | CXC chemokine receptor antagonist | |||
| 0.115 | 0.012 | 0.115 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.086 0.018 CID_7258 0.081 0.02 CID_11334 | ||
| 0.108 | 0.005 | 0.108 | Corticotropin releasing factor 2 receptor antagonist | 0.076 0.02 CID_7258 0.065 0.036 CID_11334 | ||
| 0.111 | 0.009 | 0.111 | Glutamate (mGluR group III) agonist | 0.053 0.022 CID_7258 0.076 0.014 CID_11334 | ||
| 0.139 | 0.038 | 0.139 | Photosensitizer | 0.128 0.048 CID_7258 0.114 0.065 CID_11334 | ||
| 0.122 | 0.021 | 0.144 | Glutathione S-transferase inhibitor | 0.144 0.013 CID_7258 0.133 0.017 CID_11334 | CID_7258 | |
| 0.105 | 0.004 | 0.105 | Potassium channel (ATP-sensitive) activator | 0.07 0.01 CID_7258 0.065 0.012 CID_11334 | ||
| 0.113 | 0.013 | 0.174 | NMDA 2B receptor antagonist | 0.174 0.007 CID_7258 0.05 0.043 CID_11334 | CID_7258 | |
| 0.125 | 0.026 | 0.125 | Cathepsin G inhibitor | 0.1 0.033 CID_7258 0.084 0.041 CID_11334 | ||
| 0.113 | 0.014 | 0.113 | Acetylcholine M5 receptor agonist | |||
| 0.141 | 0.043 | 0.141 | Microtubule formation inhibitor | 0.125 0.055 CID_7258 0.14 0.043 CID_11334 | ||
| 0.101 | 0.003 | 0.131 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.117 0.002 CID_7258 0.131 0.002 CID_11334 | CID_11334 | |
| 0.186 | 0.088 | 0.187 | Insulin sensitizer | 0.187 0.087 CID_7258 0.169 0.108 CID_11334 | CID_7258 | |
| 0.172 | 0.074 | 0.172 | Tumour necrosis factor antagonist | 0.135 0.12 CID_7258 | ||
| 0.112 | 0.014 | 0.156 | Estrogen-related receptor beta agonist | 0.156 0.004 CID_7258 0.124 0.009 CID_11334 | CID_7258 | |
| 0.118 | 0.021 | 0.163 | Dopamine agonist | 0.163 0.013 CID_7258 0.128 0.018 CID_11334 | CID_7258 | |
| 0.162 | 0.064 | 0.162 | Acetylcholine M1 receptor antagonist | 0.133 0.092 CID_7258 0.123 0.104 CID_11334 | ||
| 0.15 | 0.053 | 0.186 | Toll-Like receptor 2 antagonist | 0.186 0.03 CID_7258 0.161 0.045 CID_11334 | CID_7258 | |
| 0.11 | 0.013 | 0.11 | Cannabinoid CB2 receptor antagonist | 0.086 0.018 CID_7258 0.059 0.03 CID_11334 | ||
| 0.118 | 0.021 | 0.139 | Bile acid receptor antagonist | 0.139 0.01 CID_7258 0.115 0.024 CID_11334 | CID_7258 | |
| 0.161 | 0.064 | 0.294 | Heat shock protein 90 antagonist | 0.27 0.015 CID_7258 0.294 0.011 CID_11334 | CID_11334 | |
| 0.1 | 0.004 | 0.1 | Kynurenine 3 monooxygenase inhibitor | 0.073 0.004 CID_7258 0.052 0.006 CID_11334 | ||
| 0.15 | 0.054 | 0.15 | Cyclooxygenase 2 inhibitor | 0.131 0.069 CID_7258 | ||
| 0.116 | 0.021 | 0.116 | Aminopeptidase I inhibitor | 0.101 0.027 CID_7258 0.091 0.033 CID_11334 | ||
| 0.148 | 0.052 | 0.191 | MAP kinase kinase inhibitor | 0.191 0.031 CID_7258 0.137 0.059 CID_11334 | CID_7258 | |
| 0.117 | 0.022 | 0.138 | Carbonic anhydrase V inhibitor | 0.138 0.017 CID_7258 0.126 0.02 CID_11334 | CID_7258 | |
| 0.12 | 0.025 | 0.234 | Macrophage migration inhibitory factor inhibitor | 0.234 0.005 CID_7258 0.185 0.009 CID_11334 | CID_7258 | |
| 0.125 | 0.03 | 0.151 | Protein kinase C zeta inhibitor | 0.151 0.02 CID_7258 0.138 0.023 CID_11334 | CID_7258 | |
| 0.135 | 0.041 | 0.135 | Caspase 3 inhibitor | 0.13 0.046 CID_7258 0.115 0.067 CID_11334 | ||
| 0.099 | 0.004 | 0.146 | Dopamine D5 agonist | 0.146 0.003 CID_7258 0.123 0.003 CID_11334 | CID_7258 | |
| 0.098 | 0.004 | 0.102 | Pregnane X receptor antagonist | 0.102 0.004 CID_7258 0.088 0.005 CID_11334 | CID_7258 | |
| 0.113 | 0.019 | 0.113 | Benzodiazepine agonist | |||
| 0.106 | 0.012 | 0.141 | NMDA 2A receptor antagonist | 0.141 0.008 CID_7258 0.091 0.016 CID_11334 | CID_7258 | |
| 0.098 | 0.004 | 0.098 | 5 Hydroxytryptamine 2B agonist | 0.063 0.008 CID_7258 0.047 0.016 CID_11334 | ||
| 0.136 | 0.043 | 0.173 | MAO B inhibitor | 0.172 0.031 CID_7258 0.173 0.03 CID_11334 | CID_11334 | |
| 0.115 | 0.022 | 0.129 | Myeloperoxidase inhibitor | 0.129 0.016 CID_7258 0.098 0.038 CID_11334 | CID_7258 | |
| 0.097 | 0.004 | 0.097 | Adenylate cyclase 1 inhibitor | 0.083 0.007 CID_7258 0.075 0.01 CID_11334 | ||
| 0.134 | 0.042 | 0.134 | Protein kinase C gamma inhibitor | 0.129 0.046 CID_7258 0.096 0.084 CID_11334 | ||
| 0.141 | 0.049 | 0.158 | Vanilloid 1 agonist | 0.149 0.039 CID_7258 0.158 0.031 CID_11334 | CID_11334 | |
| 0.101 | 0.009 | 0.101 | 5 Hydroxytryptamine 2 agonist | 0.073 0.018 CID_7258 0.086 0.013 CID_11334 | ||
| 0.106 | 0.015 | 0.108 | Carbonic anhydrase VB inhibitor | 0.108 0.014 CID_7258 0.078 0.023 CID_11334 | CID_7258 | |
| 0.124 | 0.032 | 0.217 | Alcohol dehydrogenase inhibitor | 0.217 0.011 CID_7258 0.114 0.039 CID_11334 | CID_7258 | |
| 0.132 | 0.041 | 0.132 | CDK3/cyclin E inhibitor | 0.124 0.05 CID_11334 | ||
| 0.099 | 0.008 | 0.099 | Sphingosine kinase 2 inhibitor | 0.098 0.008 CID_7258 0.085 0.013 CID_11334 | ||
| 0.121 | 0.031 | 0.121 | Potassium channel (Voltage-sensitive) activator | |||
| 0.096 | 0.006 | 0.096 | Glutamate (mGluR4) antagonist | 0.056 0.016 CID_7258 0.052 0.019 CID_11334 | ||
| 0.136 | 0.046 | 0.136 | Alpha 2b adrenoreceptor antagonist | 0.108 0.068 CID_7258 | ||
| 0.109 | 0.02 | 0.109 | Amidase inhibitor | 0.092 0.029 CID_7258 0.067 0.054 CID_11334 | ||
| 0.098 | 0.01 | 0.098 | Potassium channel (Tandem pore domain) blocker | 0.07 0.065 CID_7258 0.069 0.067 CID_11334 | ||
| 0.109 | 0.021 | 0.123 | Carbonic anhydrase VA inhibitor | 0.123 0.017 CID_7258 0.084 0.034 CID_11334 | CID_7258 | |
| 0.105 | 0.018 | 0.105 | Argininosuccinate synthase inhibitor | 0.077 0.026 CID_7258 0.072 0.029 CID_11334 | ||
| 0.1 | 0.013 | 0.1 | Phosphorylase inhibitor | 0.09 0.014 CID_7258 0.066 0.022 CID_11334 | ||
| 0.192 | 0.105 | 0.275 | Antiamyloidogenic | 0.275 0.061 CID_7258 | CID_7258 | |
| 0.135 | 0.048 | 0.135 | DNA repair enzyme inhibitor | 0.129 0.056 CID_7258 0.112 0.09 CID_11334 | ||
| 0.12 | 0.033 | 0.164 | Androgen antagonist | 0.164 0.019 CID_7258 0.132 0.028 CID_11334 | CID_7258 | |
| 0.213 | 0.127 | 0.306 | Lipoxygenase inhibitor | 0.304 0.069 CID_7258 0.306 0.068 CID_11334 | CID_11334 | |
| 0.104 | 0.018 | 0.105 | CC chemokine 5 receptor agonist | 0.105 0.017 CID_7258 0.094 0.029 CID_11334 | CID_7258 | |
| 0.092 | 0.006 | 0.092 | Dihydroorotate oxidase inhibitor | 0.091 0.006 CID_7258 0.082 0.009 CID_11334 | ||
| 0.09 | 0.005 | 0.09 | Glucagon-like peptide 1 receptor antagonist | 0.05 0.013 CID_7258 | ||
| 0.099 | 0.015 | 0.099 | Alpha 2 adrenoreceptor agonist | 0.074 0.028 CID_7258 0.055 0.05 CID_11334 | ||
| 0.101 | 0.017 | 0.101 | TRPA1 antagonist | 0.092 0.02 CID_7258 | ||
| 0.087 | 0.004 | 0.087 | Alpha 1d adrenoreceptor agonist | 0.062 0.01 CID_7258 0.055 0.013 CID_11334 | ||
| 0.166 | 0.083 | 0.279 | Dual specificity phosphatase 3 inhibitor | 0.279 0.033 CID_7258 0.163 0.086 CID_11334 | CID_7258 | |
| 0.143 | 0.061 | 0.2 | Cyclooxygenase 1 inhibitor | 0.2 0.034 CID_7258 | CID_7258 | |
| 0.087 | 0.005 | 0.102 | Purinergic P2X4 antagonist | 0.102 0.005 CID_7258 0.067 0.01 CID_11334 | CID_7258 | |
| 0.144 | 0.062 | 0.144 | Interleukin 1 antagonist | |||
| 0.09 | 0.009 | 0.09 | 5 Hydroxytryptamine 2C agonist | 0.048 0.029 CID_11334 | ||
| 0.093 | 0.012 | 0.151 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.149 0.005 CID_7258 0.151 0.005 CID_11334 | CID_11334 | |
| 0.088 | 0.007 | 0.088 | Glucose-6-phosphate isomerase inhibitor | 0.08 0.009 CID_7258 0.075 0.01 CID_11334 | ||
| 0.085 | 0.004 | 0.085 | Heme oxygenase inhibitor | 0.06 0.006 CID_7258 0.057 0.007 CID_11334 | ||
| 0.16 | 0.079 | 0.16 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.093 | 0.013 | 0.093 | Neurokinin antagonist | |||
| 0.263 | 0.183 | 0.263 | DNA directed DNA polymerase inhibitor | 0.255 0.189 CID_7258 0.223 0.21 CID_11334 | ||
| 0.104 | 0.024 | 0.104 | Caspase 7 inhibitor | 0.089 0.043 CID_7258 | ||
| 0.174 | 0.095 | 0.174 | Focal adhesion kinase 2 inhibitor | |||
| 0.144 | 0.064 | 0.144 | Calcium channel blocker | |||
| 0.152 | 0.072 | 0.174 | Phospholipase A2 inhibitor | 0.174 0.057 CID_7258 0.149 0.075 CID_11334 | CID_7258 | |
| 0.085 | 0.006 | 0.085 | Kainate receptor 2 antagonist | 0.059 0.012 CID_7258 0.046 0.018 CID_11334 | ||
| 0.128 | 0.05 | 0.128 | GABA receptor agonist | |||
| 0.135 | 0.056 | 0.153 | Adenylate cyclase inhibitor | 0.136 0.055 CID_7258 0.153 0.043 CID_11334 | CID_11334 | |
| 0.137 | 0.058 | 0.137 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.13 | 0.052 | 0.13 | Calcium channel N-type blocker | |||
| 0.127 | 0.05 | 0.127 | MAP kinase 13 inhibitor | |||
| 0.083 | 0.006 | 0.083 | GABA B receptor antagonist | 0.058 0.013 CID_7258 0.049 0.021 CID_11334 | ||
| 0.108 | 0.031 | 0.108 | Inducible nitric-oxide synthase inhibitor | 0.098 0.039 CID_7258 | ||
| 0.117 | 0.04 | 0.139 | DNA directed RNA polymerase inhibitor | 0.139 0.028 CID_7258 | CID_7258 | |
| 0.257 | 0.181 | 0.257 | Transcription factor inhibitor | 0.218 0.211 CID_7258 | ||
| 0.198 | 0.122 | 0.239 | Immunostimulant | 0.239 0.101 CID_7258 0.221 0.108 CID_11334 | CID_7258 | |
| 0.099 | 0.024 | 0.099 | Ca(v)3.1 blocker | |||
| 0.102 | 0.027 | 0.102 | Cyclin B3 inhibitor | 0.073 0.043 CID_7258 0.093 0.031 CID_11334 | ||
| 0.157 | 0.083 | 0.22 | Mcl-1 antagonist | 0.22 0.046 CID_7258 0.126 0.118 CID_11334 | CID_7258 | |
| 0.085 | 0.011 | 0.097 | Opioid kappa receptor agonist | 0.097 0.01 CID_7258 0.041 0.033 CID_11334 | CID_7258 | |
| 0.079 | 0.005 | 0.079 | Potassium channel Kv1.1 blocker | 0.043 0.019 CID_7258 0.04 0.023 CID_11334 | ||
| 0.146 | 0.073 | 0.146 | Hemostatic | 0.138 0.084 CID_7258 | ||
| 0.078 | 0.004 | 0.078 | Phenylethanolamine N methyltransferase inhibitor | 0.05 0.014 CID_7258 0.043 0.023 CID_11334 | ||
| 0.078 | 0.004 | 0.078 | Nerve growth factor antagonist | 0.055 0.013 CID_7258 0.056 0.012 CID_11334 | ||
| 0.097 | 0.024 | 0.098 | Sphingosine 1-phosphate receptor antagonist | 0.093 0.027 CID_7258 0.098 0.022 CID_11334 | CID_11334 | |
| 0.087 | 0.014 | 0.087 | Botulinum neurotoxin type A inhibitor | 0.082 0.016 CID_7258 0.081 0.016 CID_11334 | ||
| 0.097 | 0.024 | 0.097 | Glucagon-like peptide 1 agonist | 0.078 0.036 CID_7258 | ||
| 0.107 | 0.034 | 0.13 | Interleukin 5 antagonist | 0.13 0.018 CID_7258 | CID_7258 | |
| 0.088 | 0.016 | 0.088 | CC chemokine 2 receptor antagonist | 0.065 0.028 CID_7258 0.054 0.038 CID_11334 | ||
| 0.094 | 0.022 | 0.094 | Cannabinoid CB1 receptor agonist | |||
| 0.096 | 0.025 | 0.096 | Nav1.7 sodium channel blocker | 0.063 0.053 CID_7258 | ||
| 0.113 | 0.042 | 0.113 | Interleukin 1 beta converting enzyme inhibitor | 0.112 0.043 CID_7258 0.084 0.082 CID_11334 | ||
| 0.13 | 0.06 | 0.13 | Anesthetic local | |||
| 0.089 | 0.019 | 0.109 | Androgen agonist | 0.109 0.012 CID_7258 0.09 0.019 CID_11334 | CID_7258 | |
| 0.077 | 0.008 | 0.077 | Glutamate (mGluR group III) antagonist | 0.051 0.02 CID_7258 0.048 0.023 CID_11334 | ||
| 0.127 | 0.058 | 0.161 | Protein kinase (CK2) alpha inhibitor | 0.123 0.06 CID_7258 0.161 0.036 CID_11334 | CID_11334 | |
| 0.096 | 0.027 | 0.096 | Calcium channel L-type blocker | |||
| 0.076 | 0.007 | 0.076 | Immunoglobulin Fc receptor antagonist | 0.064 0.017 CID_7258 0.061 0.022 CID_11334 | ||
| 0.104 | 0.035 | 0.143 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.143 0.021 CID_7258 0.119 0.029 CID_11334 | CID_7258 | |
| 0.077 | 0.008 | 0.077 | Substance P antagonist | |||
| 0.079 | 0.011 | 0.079 | Glutamate (mGluR5) agonist | |||
| 0.097 | 0.029 | 0.104 | Lipase inhibitor | 0.104 0.025 CID_7258 | CID_7258 | |
| 0.074 | 0.006 | 0.074 | Benzodiazepine antagonist | 0.055 0.018 CID_7258 0.046 0.037 CID_11334 | ||
| 0.077 | 0.009 | 0.077 | Somatostatin 4 agonist | |||
| 0.121 | 0.053 | 0.132 | Mucolytic | 0.132 0.045 CID_7258 0.117 0.057 CID_11334 | CID_7258 | |
| 0.077 | 0.01 | 0.077 | Kainate receptor antagonist | 0.068 0.013 CID_7258 0.043 0.026 CID_11334 | ||
| 0.253 | 0.186 | 0.343 | Alpha-glucosidase inhibitor | 0.343 0.139 CID_7258 0.257 0.183 CID_11334 | CID_7258 | |
| 0.215 | 0.149 | 0.246 | Thyroid hormone antagonist | 0.246 0.126 CID_7258 0.231 0.136 CID_11334 | CID_7258 | |
| 0.094 | 0.027 | 0.145 | Dopamine D1 antagonist | 0.145 0.016 CID_7258 0.142 0.016 CID_11334 | CID_7258 | |
| 0.111 | 0.045 | 0.111 | Nitric-oxide synthase inhibitor | 0.091 0.075 CID_7258 | ||
| 0.083 | 0.016 | 0.083 | Glycine transporter inhibitor | 0.042 0.039 CID_7258 0.046 0.034 CID_11334 | ||
| 0.09 | 0.024 | 0.09 | Bcl2 antagonist | 0.086 0.027 CID_7258 | ||
| 0.116 | 0.051 | 0.157 | Protein kinase (CK2) inhibitor | 0.119 0.049 CID_7258 0.157 0.03 CID_11334 | CID_11334 | |
| 0.109 | 0.043 | 0.109 | Ca(v)2.2 blocker | |||
| 0.083 | 0.017 | 0.117 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.117 0.006 CID_7258 0.095 0.012 CID_11334 | CID_7258 | |
| 0.07 | 0.005 | 0.07 | p53 inhibitor | |||
| 0.077 | 0.012 | 0.077 | Aldosterone antagonist | 0.044 0.039 CID_7258 | ||
| 0.078 | 0.013 | 0.078 | Epithelial sodium channel blocker | 0.076 0.014 CID_7258 0.055 0.038 CID_11334 | ||
| 0.112 | 0.047 | 0.112 | Hedgehog signaling inhibitor | |||
| 0.21 | 0.146 | 0.232 | Thyroid hormone beta antagonist | 0.232 0.13 CID_7258 0.219 0.139 CID_11334 | CID_7258 | |
| 0.069 | 0.005 | 0.069 | Alpha 1L adrenoreceptor agonist | |||
| 0.08 | 0.016 | 0.08 | Glucosylceramidase inhibitor | 0.069 0.022 CID_7258 0.059 0.032 CID_11334 | ||
| 0.072 | 0.008 | 0.072 | Fumarate hydratase inhibitor | 0.054 0.012 CID_7258 0.049 0.014 CID_11334 | ||
| 0.166 | 0.103 | 0.166 | I kappa B kinase epsilon inhibitor | |||
| 0.075 | 0.012 | 0.104 | Nicotinic acid receptor 1 agonist | 0.104 0.007 CID_7258 | CID_7258 | |
| 0.092 | 0.029 | 0.092 | Dopamine D4 antagonist | 0.074 0.035 CID_7258 0.054 0.046 CID_11334 | ||
| 0.077 | 0.013 | 0.077 | Glutamate (mGluR group I) agonist | |||
| 0.07 | 0.008 | 0.075 | Dopamine beta hydroxylase inhibitor | 0.075 0.006 CID_7258 0.074 0.006 CID_11334 | CID_7258 | |
| 0.077 | 0.014 | 0.077 | 5 Hydroxytryptamine 7 agonist | 0.063 0.027 CID_7258 0.056 0.039 CID_11334 | ||
| 0.097 | 0.035 | 0.099 | Na+ K+ transporting ATPase inhibitor | 0.099 0.033 CID_7258 0.088 0.043 CID_11334 | CID_7258 | |
| 0.104 | 0.042 | 0.126 | Aminoacyl-tRNA synthetase inhibitor | 0.126 0.027 CID_7258 | CID_7258 | |
| 0.089 | 0.027 | 0.105 | MAP kinase kinase 7 inhibitor | 0.105 0.009 CID_7258 0.092 0.021 CID_11334 | CID_7258 | |
| 0.087 | 0.025 | 0.087 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.066 | 0.005 | 0.121 | ATP citrate lysase inhibitor | 0.121 0.003 CID_7258 0.098 0.003 CID_11334 | CID_7258 | |
| 0.099 | 0.038 | 0.099 | Glutamate receptor agonist | 0.08 0.053 CID_11334 | ||
| 0.065 | 0.004 | 0.065 | Integrin alpha1beta1 antagonist | 0.039 0.024 CID_7258 0.038 0.027 CID_11334 | ||
| 0.125 | 0.064 | 0.125 | MAP kinase 12 inhibitor | |||
| 0.065 | 0.005 | 0.074 | Protein kinase (CK2) beta inhibitor | 0.074 0.004 CID_7258 0.045 0.009 CID_11334 | CID_7258 | |
| 0.135 | 0.075 | 0.135 | Cytokine production inhibitor | |||
| 0.078 | 0.018 | 0.078 | AMPA receptor antagonist | 0.051 0.03 CID_7258 | ||
| 0.091 | 0.031 | 0.091 | Adenosine A3 receptor antagonist | 0.074 0.052 CID_7258 0.071 0.057 CID_11334 | ||
| 0.064 | 0.004 | 0.083 | CF transmembrane conductance regulator antagonist | 0.08 0.003 CID_7258 0.083 0.003 CID_11334 | CID_11334 | |
| 0.064 | 0.004 | 0.064 | Vanilloid 3 antagonist | 0.052 0.007 CID_7258 0.053 0.007 CID_11334 | ||
| 0.072 | 0.013 | 0.072 | Squalene epoxidase inhibitor | 0.066 0.016 CID_7258 0.059 0.021 CID_11334 | ||
| 0.093 | 0.033 | 0.093 | Transforming growth factor beta 3 antagonist | |||
| 0.075 | 0.016 | 0.075 | Sphingosine 1-phosphate receptor 1 antagonist | 0.069 0.019 CID_7258 0.061 0.028 CID_11334 | ||
| 0.065 | 0.006 | 0.065 | Histamine H1 receptor agonist | |||
| 0.096 | 0.037 | 0.096 | Cell adhesion molecule inhibitor | |||
| 0.081 | 0.022 | 0.081 | Prostaglandin antagonist | |||
| 0.114 | 0.056 | 0.161 | MAO A inhibitor | 0.161 0.038 CID_7258 0.149 0.041 CID_11334 | CID_7258 | |
| 0.062 | 0.005 | 0.088 | CXC chemokine 2 receptor antagonist | 0.088 0.004 CID_7258 0.087 0.004 CID_11334 | CID_7258 | |
| 0.063 | 0.006 | 0.063 | Kainate receptor agonist | 0.055 0.009 CID_7258 0.053 0.011 CID_11334 | ||
| 0.076 | 0.019 | 0.076 | Kallikrein 7 inhibitor | 0.068 0.034 CID_7258 | ||
| 0.113 | 0.056 | 0.113 | MAP kinase kinase kinase inhibitor | |||
| 0.08 | 0.023 | 0.102 | Prostaglandin F2 alpha antagonist | 0.102 0.011 CID_7258 | CID_7258 | |
| 0.08 | 0.023 | 0.08 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.07 | 0.013 | 0.081 | CXC chemokine 1 receptor antagonist | 0.081 0.008 CID_7258 0.073 0.011 CID_11334 | CID_7258 | |
| 0.078 | 0.021 | 0.078 | Thromboxane antagonist | 0.067 0.028 CID_7258 0.055 0.036 CID_11334 | ||
| 0.065 | 0.009 | 0.065 | Sirtuin 2 inhibitor | 0.038 0.019 CID_7258 0.04 0.017 CID_11334 | ||
| 0.069 | 0.013 | 0.069 | Fructose-1,6-bisphosphatase inhibitor | 0.055 0.021 CID_7258 0.042 0.036 CID_11334 | ||
| 0.118 | 0.062 | 0.118 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.086 | 0.03 | 0.086 | Secretase beta inhibitor | 0.065 0.06 CID_7258 | ||
| 0.067 | 0.012 | 0.067 | Cholesterol esterase inhibitor | 0.05 0.03 CID_7258 0.047 0.034 CID_11334 | ||
| 0.06 | 0.005 | 0.06 | NMDA receptor glycine site antagonist | 0.048 0.006 CID_7258 0.043 0.007 CID_11334 | ||
| 0.079 | 0.024 | 0.106 | Beta 3 adrenoreceptor antagonist | 0.102 0.014 CID_7258 0.106 0.013 CID_11334 | CID_11334 | |
| 0.061 | 0.007 | 0.061 | Glutamate (mGluR8) agonist | 0.053 0.01 CID_7258 0.05 0.012 CID_11334 | ||
| 0.079 | 0.025 | 0.116 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.116 0.013 CID_7258 0.09 0.02 CID_11334 | CID_7258 | |
| 0.067 | 0.013 | 0.067 | Carnitine palmitoyltransferase 1B inhibitor | 0.044 0.04 CID_7258 | ||
| 0.063 | 0.009 | 0.063 | AMPA 4 receptor antagonist | 0.052 0.014 CID_7258 0.044 0.02 CID_11334 | ||
| 0.076 | 0.022 | 0.076 | Cyclin D1 inhibitor | 0.064 0.036 CID_7258 0.057 0.048 CID_11334 | ||
| 0.09 | 0.037 | 0.09 | Acetylcholine M4 receptor antagonist | |||
| 0.076 | 0.023 | 0.134 | Heat shock protein 90 beta antagonist | 0.134 0.005 CID_7258 0.106 0.009 CID_11334 | CID_7258 | |
| 0.099 | 0.046 | 0.099 | Protein kinase A inhibitor | |||
| 0.062 | 0.009 | 0.062 | GABA uptake inhibitor | 0.044 0.021 CID_7258 0.046 0.019 CID_11334 | ||
| 0.062 | 0.01 | 0.062 | Guanylate cyclase inhibitor | 0.051 0.02 CID_7258 0.048 0.023 CID_11334 | ||
| 0.063 | 0.01 | 0.065 | Phosphoglycerate kinase inhibitor | 0.058 0.012 CID_7258 0.065 0.01 CID_11334 | CID_11334 | |
| 0.06 | 0.007 | 0.06 | Integrin alpha2 antagonist | 0.039 0.022 CID_7258 0.04 0.021 CID_11334 | ||
| 0.135 | 0.082 | 0.135 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.075 | 0.023 | 0.075 | Transcription factor RelA inhibitor | 0.072 0.026 CID_7258 0.066 0.037 CID_11334 | ||
| 0.072 | 0.02 | 0.072 | Thromboxane A2 antagonist | 0.062 0.027 CID_7258 0.052 0.034 CID_11334 | ||
| 0.056 | 0.004 | 0.056 | Alpha 2a adrenoreceptor agonist | 0.032 0.005 CID_7258 0.026 0.006 CID_11334 | ||
| 0.077 | 0.025 | 0.077 | 5 Hydroxytryptamine 5A antagonist | 0.061 0.043 CID_7258 | ||
| 0.061 | 0.009 | 0.061 | Dihydrofolate reductase inhibitor | 0.05 0.019 CID_7258 0.043 0.031 CID_11334 | ||
| 0.064 | 0.013 | 0.064 | Histamine H2 receptor agonist | |||
| 0.064 | 0.012 | 0.064 | Thymidine kinase inhibitor | 0.051 0.018 CID_7258 0.046 0.022 CID_11334 | ||
| 0.073 | 0.021 | 0.073 | Phosphodiesterase 1A inhibitor | |||
| 0.073 | 0.022 | 0.073 | Sphingosine kinase inhibitor | 0.073 0.021 CID_7258 0.064 0.033 CID_11334 | ||
| 0.109 | 0.058 | 0.109 | Alpha 2c adrenoreceptor antagonist | 0.084 0.083 CID_7258 | ||
| 0.115 | 0.064 | 0.115 | Calcium channel (voltage-sensitive) blocker | |||
| 0.069 | 0.018 | 0.069 | Alpha-mannosidase inhibitor | 0.063 0.023 CID_7258 0.058 0.029 CID_11334 | ||
| 0.056 | 0.005 | 0.056 | LFA antagonist | 0.03 0.015 CID_7258 0.027 0.021 CID_11334 | ||
| 0.079 | 0.029 | 0.079 | Potassium channel (ATP-sensitive) blocker | 0.073 0.036 CID_7258 | ||
| 0.097 | 0.047 | 0.097 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.085 | 0.035 | 0.085 | Alpha adrenoreceptor agonist | 0.07 0.046 CID_7258 | ||
| 0.074 | 0.025 | 0.074 | Phosphodiesterase 1C inhibitor | 0.059 0.051 CID_7258 | ||
| 0.094 | 0.045 | 0.094 | Histamine H1 receptor antagonist | |||
| 0.086 | 0.038 | 0.093 | HIV-1 reverse transcriptase inhibitor | 0.093 0.034 CID_7258 | CID_7258 | |
| 0.082 | 0.034 | 0.082 | Cannabinoid receptor agonist | |||
| 0.064 | 0.016 | 0.064 | Histamine H4 receptor antagonist | |||
| 0.057 | 0.009 | 0.057 | Glutamate (mGluR4) agonist | 0.036 0.02 CID_7258 0.033 0.025 CID_11334 | ||
| 0.053 | 0.005 | 0.053 | Methionyl aminopeptidase 1 inhibitor | 0.032 0.022 CID_7258 | ||
| 0.142 | 0.094 | 0.142 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.058 | 0.011 | 0.06 | Farnesoid X receptor agonist | 0.06 0.01 CID_7258 0.051 0.014 CID_11334 | CID_7258 | |
| 0.06 | 0.013 | 0.06 | Glycine transporter 1 inhibitor | |||
| 0.062 | 0.015 | 0.062 | Dihydroorotase inhibitor | 0.044 0.033 CID_7258 0.043 0.033 CID_11334 | ||
| 0.054 | 0.007 | 0.054 | Free fatty acid receptor 1 antagonist | 0.046 0.011 CID_7258 0.041 0.015 CID_11334 | ||
| 0.07 | 0.023 | 0.07 | Sigma receptor antagonist | |||
| 0.051 | 0.005 | 0.051 | Tryptophan 5 hydroxylase inhibitor | 0.041 0.013 CID_7258 0.037 0.021 CID_11334 | ||
| 0.264 | 0.218 | 0.318 | MAP kinase 1 inhibitor | 0.318 0.162 CID_11334 | CID_11334 | |
| 0.104 | 0.058 | 0.122 | Folate antagonist | 0.122 0.037 CID_7258 | CID_7258 | |
| 0.06 | 0.014 | 0.06 | Geranyltranstransferase inhibitor | 0.046 0.027 CID_7258 0.044 0.03 CID_11334 | ||
| 0.062 | 0.016 | 0.062 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.064 | 0.018 | 0.064 | Heparanase inhibitor | 0.059 0.025 CID_7258 0.056 0.031 CID_11334 | ||
| 0.063 | 0.018 | 0.063 | Bromodomain-containing protein 3 inhibitor | |||
| 0.07 | 0.025 | 0.07 | Ornithine carbamoyltransferase inhibitor | 0.051 0.039 CID_7258 0.046 0.044 CID_11334 | ||
| 0.084 | 0.038 | 0.084 | Epoxide hydrolase inhibitor | |||
| 0.063 | 0.018 | 0.063 | Neurokinin 3 antagonist | |||
| 0.071 | 0.026 | 0.071 | 5 Hydroxytryptamine 5 antagonist | 0.055 0.046 CID_7258 | ||
| 0.095 | 0.051 | 0.095 | Phosphodiesterase I inhibitor | 0.086 0.065 CID_7258 | ||
| 0.094 | 0.05 | 0.094 | Epidermal growth factor antagonist | |||
| 0.067 | 0.023 | 0.067 | Dihydroorotate dehydrogenase inhibitor | 0.061 0.027 CID_7258 0.052 0.036 CID_11334 | ||
| 0.052 | 0.008 | 0.052 | Uridine phosphorylase inhibitor | 0.05 0.008 CID_7258 0.041 0.011 CID_11334 | ||
| 0.063 | 0.018 | 0.063 | Nicotinic receptor alpha3 subunit antagonist | 0.048 0.026 CID_7258 | ||
| 0.07 | 0.026 | 0.07 | GABA receptor antagonist | 0.058 0.034 CID_7258 | ||
| 0.065 | 0.02 | 0.065 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.063 | 0.019 | 0.065 | CD45 antagonist | 0.065 0.018 CID_7258 0.062 0.02 CID_11334 | CID_7258 | |
| 0.072 | 0.028 | 0.072 | EphB4 antagonist | 0.058 0.04 CID_7258 0.058 0.041 CID_11334 | ||
| 0.096 | 0.053 | 0.125 | Thioredoxin inhibitor | 0.125 0.027 CID_7258 | CID_7258 | |
| 0.048 | 0.005 | 0.048 | Thymidine phosphorylase inhibitor | 0.035 0.008 CID_7258 0.032 0.01 CID_11334 | ||
| 0.085 | 0.041 | 0.162 | Estrogen receptor alpha antagonist | 0.162 0.01 CID_7258 0.128 0.016 CID_11334 | CID_7258 | |
| 0.055 | 0.012 | 0.055 | Diamine oxidase inhibitor | |||
| 0.097 | 0.054 | 0.098 | ABCA1 expression enhancer | 0.098 0.052 CID_7258 | CID_7258 | |
| 0.079 | 0.037 | 0.079 | Orexin receptor 1 antagonist | |||
| 0.062 | 0.019 | 0.062 | Oleamide hydrolase inhibitor | 0.042 0.035 CID_7258 | ||
| 0.055 | 0.013 | 0.055 | Glutamate (mGluR group II) antagonist | 0.037 0.029 CID_7258 0.047 0.018 CID_11334 | ||
| 0.061 | 0.019 | 0.061 | CC chemokine 3 receptor antagonist | 0.039 0.031 CID_7258 | ||
| 0.124 | 0.082 | 0.124 | Toll-Like receptor 9 antagonist | |||
| 0.046 | 0.005 | 0.046 | Integrin alpha2beta1 antagonist | 0.029 0.014 CID_7258 0.029 0.014 CID_11334 | ||
| 0.063 | 0.021 | 0.069 | Glucose-6-phosphate translocase inhibitor | 0.069 0.016 CID_7258 0.056 0.029 CID_11334 | CID_7258 | |
| 0.086 | 0.044 | 0.086 | Alpha 2a adrenoreceptor antagonist | 0.065 0.064 CID_7258 | ||
| 0.05 | 0.009 | 0.05 | Lysophosphatidic acid 2 receptor antagonist | 0.033 0.018 CID_7258 0.032 0.019 CID_11334 | ||
| 0.046 | 0.005 | 0.046 | Glutamate (mGluR1a) agonist | 0.024 0.013 CID_7258 0.02 0.018 CID_11334 | ||
| 0.049 | 0.008 | 0.049 | Ceramide glucosyltransferase inhibitor | 0.045 0.011 CID_7258 0.042 0.014 CID_11334 | ||
| 0.113 | 0.072 | 0.113 | Cell adhesion inhibitor | |||
| 0.122 | 0.081 | 0.122 | Toll-Like receptor antagonist | |||
| 0.047 | 0.007 | 0.073 | Sodium/glucose cotransporter 2 inhibitor | 0.073 0.004 CID_7258 0.044 0.007 CID_11334 | CID_7258 | |
| 0.049 | 0.009 | 0.049 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.041 0.011 CID_7258 0.028 0.019 CID_11334 | ||
| 0.048 | 0.008 | 0.048 | Benzodiazepine receptor peripheral-type antagonist | 0.032 0.029 CID_7258 | ||
| 0.061 | 0.021 | 0.061 | Lysophosphatidic acid 3 receptor antagonist | 0.047 0.04 CID_7258 0.046 0.042 CID_11334 | ||
| 0.073 | 0.033 | 0.073 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.112 | 0.072 | 0.112 | Proteasome inhibitor | |||
| 0.051 | 0.011 | 0.051 | AMPA 1 receptor antagonist | 0.044 0.013 CID_7258 0.025 0.024 CID_11334 | ||
| 0.063 | 0.024 | 0.063 | Thromboxane synthase inhibitor | 0.054 0.038 CID_7258 0.05 0.049 CID_11334 | ||
| 0.066 | 0.027 | 0.066 | GABA A receptor antagonist | 0.054 0.036 CID_7258 | ||
| 0.055 | 0.016 | 0.059 | Liver X receptor alpha agonist | 0.059 0.013 CID_7258 0.044 0.024 CID_11334 | CID_7258 | |
| 0.068 | 0.028 | 0.068 | Sphingosine 1-phosphate receptor 3 antagonist | 0.058 0.041 CID_7258 | ||
| 0.053 | 0.014 | 0.088 | Nicotinic acid receptor agonist | 0.088 0.005 CID_7258 0.062 0.01 CID_11334 | CID_7258 | |
| 0.068 | 0.029 | 0.068 | Calcium channel T-type blocker | |||
| 0.07 | 0.031 | 0.07 | Acetylcholine M5 receptor antagonist | |||
| 0.043 | 0.004 | 0.043 | Imidazoline I1 receptor antagonist | |||
| 0.044 | 0.005 | 0.044 | Purinergic P2Y15 antagonist | 0.037 0.009 CID_7258 0.035 0.01 CID_11334 | ||
| 0.083 | 0.044 | 0.115 | Keratolytic | 0.115 0.023 CID_7258 0.09 0.037 CID_11334 | CID_7258 | |
| 0.055 | 0.016 | 0.055 | Progesterone antagonist | 0.044 0.02 CID_7258 0.041 0.022 CID_11334 | ||
| 0.045 | 0.007 | 0.045 | Nicotinic alpha3beta4 receptor agonist | 0.036 0.013 CID_7258 | ||
| 0.042 | 0.004 | 0.042 | Complement factor 1r inhibitor | |||
| 0.057 | 0.019 | 0.057 | Mannosidase inhibitor | 0.051 0.025 CID_7258 0.047 0.03 CID_11334 | ||
| 0.048 | 0.01 | 0.048 | AMPA 3 receptor antagonist | 0.033 0.018 CID_7258 0.026 0.023 CID_11334 | ||
| 0.042 | 0.004 | 0.042 | Hedgehog signaling activator | 0.037 0.005 CID_7258 0.036 0.006 CID_11334 | ||
| 0.062 | 0.025 | 0.062 | Leukotriene C antagonist | 0.062 0.026 CID_7258 0.061 0.028 CID_11334 | ||
| 0.042 | 0.005 | 0.042 | MAP3K8 inhibitor | |||
| 0.075 | 0.038 | 0.075 | Protein kinase C beta inhibitor | 0.068 0.051 CID_7258 | ||
| 0.049 | 0.012 | 0.049 | Delayed rectifier potassium channel blocker | 0.037 0.027 CID_7258 | ||
| 0.07 | 0.034 | 0.083 | Aromatase inhibitor | 0.083 0.026 CID_7258 0.075 0.03 CID_11334 | CID_7258 | |
| 0.068 | 0.032 | 0.068 | Glutamate (mGluR1) antagonist | |||
| 0.085 | 0.05 | 0.085 | Thioredoxin reductase inhibitor | 0.081 0.058 CID_7258 | ||
| 0.047 | 0.012 | 0.088 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.088 0.005 CID_7258 0.074 0.005 CID_11334 | CID_7258 | |
| 0.059 | 0.024 | 0.059 | Bombesin 2 receptor antagonist | 0.051 0.032 CID_7258 0.046 0.04 CID_11334 | ||
| 0.039 | 0.004 | 0.039 | Cyclin T1 inhibitor | 0.02 0.011 CID_7258 0.018 0.013 CID_11334 | ||
| 0.103 | 0.069 | 0.103 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.045 | 0.01 | 0.051 | Liver X receptor beta antagonist | 0.051 0.008 CID_7258 0.047 0.009 CID_11334 | CID_7258 | |
| 0.071 | 0.037 | 0.071 | Dopamine D3 antagonist | |||
| 0.041 | 0.007 | 0.041 | 5 Hydroxytryptamine 6 agonist | |||
| 0.059 | 0.025 | 0.059 | Prolyl endopeptidase inhibitor | 0.047 0.041 CID_7258 | ||
| 0.082 | 0.049 | 0.082 | Interferon agonist | |||
| 0.055 | 0.021 | 0.055 | Thymidylate synthase inhibitor | 0.048 0.031 CID_7258 0.05 0.027 CID_11334 | ||
| 0.147 | 0.114 | 0.159 | Death-associated protein kinase 2 inhibitor | 0.159 0.087 CID_7258 | CID_7258 | |
| 0.038 | 0.005 | 0.038 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.064 | 0.032 | 0.064 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.084 | 0.051 | 0.084 | Acetylcholine nicotinic antagonist | 0.07 0.068 CID_7258 | ||
| 0.074 | 0.041 | 0.074 | Neuronal nicotinic receptor antagonist | 0.06 0.054 CID_7258 | ||
| 0.058 | 0.025 | 0.058 | Phosphodiesterase 7A inhibitor | |||
| 0.037 | 0.004 | 0.037 | Alpha 2b adrenoreceptor agonist | 0.022 0.008 CID_7258 0.02 0.01 CID_11334 | ||
| 0.063 | 0.03 | 0.064 | Ryanodine receptor antagonist | 0.064 0.027 CID_7258 0.059 0.042 CID_11334 | CID_7258 | |
| 0.044 | 0.012 | 0.044 | Carnitine palmitoyltransferase 1 inhibitor | 0.033 0.026 CID_7258 | ||
| 0.035 | 0.003 | 0.035 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.023 0.004 CID_7258 0.023 0.004 CID_11334 | ||
| 0.044 | 0.012 | 0.044 | Carnitine palmitoyltransferase inhibitor | 0.032 0.027 CID_7258 | ||
| 0.038 | 0.006 | 0.038 | DNA polymerase III inhibitor | |||
| 0.048 | 0.016 | 0.048 | Arginase inhibitor | 0.046 0.018 CID_7258 0.034 0.028 CID_11334 | ||
| 0.035 | 0.004 | 0.035 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.026 0.006 CID_7258 0.026 0.006 CID_11334 | ||
| 0.053 | 0.021 | 0.053 | Stearoyl-CoA desaturase inhibitor | 0.04 0.037 CID_7258 | ||
| 0.069 | 0.037 | 0.069 | Interferon inducer | |||
| 0.056 | 0.024 | 0.056 | Potassium channel Kv1.3 blocker | 0.045 0.036 CID_7258 0.042 0.039 CID_11334 | ||
| 0.037 | 0.006 | 0.037 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.029 0.013 CID_7258 0.029 0.012 CID_11334 | ||
| 0.034 | 0.003 | 0.034 | Thromboxane A2 agonist | 0.025 0.004 CID_7258 0.024 0.004 CID_11334 | ||
| 0.037 | 0.006 | 0.037 | Nicotinic acid receptor 2 antagonist | 0.029 0.014 CID_7258 0.025 0.022 CID_11334 | ||
| 0.035 | 0.005 | 0.035 | Complement factor 1s inhibitor | 0.025 0.019 CID_7258 | ||
| 0.053 | 0.023 | 0.053 | Carbonic anhydrase IV inhibitor | 0.039 0.034 CID_7258 | ||
| 0.064 | 0.034 | 0.075 | Beta 2 adrenoreceptor agonist | 0.075 0.013 CID_7258 0.073 0.015 CID_11334 | CID_7258 | |
| 0.038 | 0.008 | 0.055 | Sodium/glucose cotransporter inhibitor | 0.055 0.005 CID_7258 0.034 0.009 CID_11334 | CID_7258 | |
| 0.056 | 0.026 | 0.062 | Topoisomerase II beta inhibitor | 0.062 0.021 CID_7258 0.049 0.034 CID_11334 | CID_7258 | |
| 0.057 | 0.027 | 0.057 | Potassium channel (Inward rectifier) blocker | |||
| 0.042 | 0.012 | 0.042 | CXC chemokine 3 receptor antagonist | |||
| 0.083 | 0.053 | 0.127 | Adrenaline agonist | 0.127 0.022 CID_7258 0.108 0.032 CID_11334 | CID_7258 | |
| 0.054 | 0.024 | 0.09 | Dopamine D2 agonist | 0.09 0.012 CID_7258 0.088 0.013 CID_11334 | CID_7258 | |
| 0.094 | 0.065 | 0.098 | Phosphodiesterase 6D inhibitor | 0.098 0.057 CID_7258 | CID_7258 | |
| 0.074 | 0.045 | 0.076 | Peroxisome proliferator-activated receptor gamma antagonist | 0.076 0.04 CID_7258 0.071 0.052 CID_11334 | CID_7258 | |
| 0.04 | 0.011 | 0.04 | Adenosine uptake inhibitor | |||
| 0.062 | 0.033 | 0.081 | Fatty acid synthase inhibitor | 0.081 0.018 CID_7258 | CID_7258 | |
| 0.038 | 0.009 | 0.043 | CC chemokine 1 receptor antagonist | 0.043 0.008 CID_7258 0.035 0.01 CID_11334 | CID_7258 | |
| 0.048 | 0.019 | 0.064 | Dihydropteroate synthase inhibitor | 0.064 0.01 CID_7258 0.04 0.027 CID_11334 | CID_7258 | |
| 0.036 | 0.008 | 0.036 | Prostaglandin H2 antagonist | 0.029 0.014 CID_7258 0.029 0.014 CID_11334 | ||
| 0.048 | 0.02 | 0.048 | Factor XIa inhibitor | |||
| 0.051 | 0.023 | 0.059 | Oxytocin agonist | 0.059 0.017 CID_7258 0.049 0.024 CID_11334 | CID_7258 | |
| 0.038 | 0.009 | 0.038 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.054 | 0.026 | 0.054 | Adenosine deaminase inhibitor | 0.045 0.035 CID_7258 0.053 0.028 CID_11334 | ||
| 0.04 | 0.012 | 0.04 | Glutamate (mGluR2) antagonist | 0.032 0.018 CID_11334 | ||
| 0.061 | 0.033 | 0.061 | Cannabinoid CB2 receptor agonist | |||
| 0.052 | 0.024 | 0.052 | Cytokine production stimulant | |||
| 0.065 | 0.037 | 0.066 | Prostaglandin EP2 antagonist | 0.066 0.036 CID_7258 | CID_7258 | |
| 0.078 | 0.05 | 0.078 | MAP kinase 11 inhibitor | |||
| 0.042 | 0.014 | 0.042 | Factor XI inhibitor | |||
| 0.039 | 0.011 | 0.048 | Glutamate (mGluR3) agonist | 0.048 0.005 CID_7258 0.038 0.012 CID_11334 | CID_7258 | |
| 0.047 | 0.02 | 0.047 | Sphingosine kinase 1 inhibitor | 0.043 0.026 CID_7258 0.039 0.033 CID_11334 | ||
| 0.04 | 0.013 | 0.04 | Cholesterol ester transfer protein antagonist | 0.033 0.02 CID_7258 0.037 0.016 CID_11334 | ||
| 0.031 | 0.005 | 0.031 | Alpha 2c adrenoreceptor agonist | |||
| 0.045 | 0.018 | 0.048 | Inosine monophosphate dehydrogenase inhibitor | 0.036 0.026 CID_7258 0.048 0.016 CID_11334 | CID_11334 | |
| 0.04 | 0.014 | 0.073 | Glucagon receptor antagonist | 0.052 0.01 CID_7258 0.073 0.005 CID_11334 | CID_11334 | |
| 0.052 | 0.026 | 0.064 | Carbonic anhydrase VII inhibitor | 0.064 0.017 CID_7258 0.052 0.025 CID_11334 | CID_7258 | |
| 0.083 | 0.057 | 0.083 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.086 | 0.06 | 0.086 | Ornithine decarboxylase inhibitor | 0.084 0.063 CID_7258 | ||
| 0.089 | 0.063 | 0.089 | Polo-like kinase-1 inhibitor | |||
| 0.035 | 0.009 | 0.043 | Estrogen-related receptor gamma antagonist | 0.043 0.004 CID_7258 0.038 0.006 CID_11334 | CID_7258 | |
| 0.04 | 0.014 | 0.04 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.033 | 0.007 | 0.033 | Acid ceramidase inhibitor | |||
| 0.04 | 0.015 | 0.046 | Liver X receptor beta agonist | 0.046 0.012 CID_7258 0.035 0.021 CID_11334 | CID_7258 | |
| 0.065 | 0.039 | 0.065 | I kappa B kinase 2 inhibitor | 0.06 0.047 CID_7258 | ||
| 0.045 | 0.02 | 0.045 | Membrane dipeptidase inhibitor | |||
| 0.032 | 0.007 | 0.032 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.027 0.011 CID_7258 0.022 0.02 CID_11334 | ||
| 0.038 | 0.013 | 0.038 | Sigma 1 receptor antagonist | |||
| 0.045 | 0.02 | 0.045 | Vascular adhesion protein 1 inhibitor | |||
| 0.087 | 0.063 | 0.087 | Pim-3 kinase inhibitor | |||
| 0.031 | 0.006 | 0.031 | ICAM 1 antagonist | 0.029 0.008 CID_7258 0.022 0.019 CID_11334 | ||
| 0.229 | 0.205 | 0.229 | DNA polymerase beta inhibitor | |||
| 0.04 | 0.016 | 0.041 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.041 0.016 CID_7258 0.04 0.017 CID_11334 | CID_7258 | |
| 0.044 | 0.02 | 0.044 | Delayed rectifier potassium channel activator | |||
| 0.044 | 0.02 | 0.044 | Potassium channel KCNQ activator | |||
| 0.049 | 0.026 | 0.049 | Secretase gamma inhibitor | |||
| 0.028 | 0.004 | 0.028 | Complement factor D inhibitor | |||
| 0.033 | 0.009 | 0.033 | Kainate receptor 1 antagonist | 0.024 0.013 CID_7258 | ||
| 0.084 | 0.061 | 0.084 | Alpha 2 adrenoreceptor antagonist | |||
| 0.033 | 0.01 | 0.033 | Myristoyl transferase inhibitor | |||
| 0.067 | 0.044 | 0.067 | Orexin receptor antagonist | |||
| 0.058 | 0.035 | 0.058 | Acetylcholine muscarinic agonist | |||
| 0.038 | 0.016 | 0.038 | Acetylcholine M4 receptor agonist | |||
| 0.053 | 0.031 | 0.053 | Antiviral (Hepatitis D) | |||
| 0.08 | 0.057 | 0.08 | Acetylcholine nicotinic agonist | |||
| 0.125 | 0.103 | 0.14 | Insulin secretagoues | 0.14 0.085 CID_7258 | CID_7258 | |
| 0.029 | 0.006 | 0.029 | Isoleucine-tRNA ligase inhibitor | 0.029 0.006 CID_7258 0.025 0.01 CID_11334 | ||
| 0.044 | 0.022 | 0.058 | Urate transporter 1 inhibitor | 0.058 0.015 CID_7258 0.051 0.018 CID_11334 | CID_7258 | |
| 0.031 | 0.008 | 0.041 | Prostaglandin F2 alpha agonist | 0.041 0.005 CID_7258 0.03 0.009 CID_11334 | CID_7258 | |
| 0.043 | 0.021 | 0.043 | TRPM8 blocker | |||
| 0.046 | 0.024 | 0.046 | Angiotensin AT1 receptor antagonist | |||
| 0.036 | 0.014 | 0.036 | Epoxide hydrolase 1 inhibitor | |||
| 0.045 | 0.023 | 0.045 | Neurokinin 1 antagonist | |||
| 0.061 | 0.039 | 0.061 | Bcl-xL inhibitor | 0.06 0.039 CID_7258 | ||
| 0.061 | 0.04 | 0.061 | Phosphodiesterase 1B inhibitor | |||
| 0.105 | 0.084 | 0.105 | Acetylcholine muscarinic antagonist | |||
| 0.052 | 0.031 | 0.064 | Carbonic anhydrase XIV inhibitor | 0.064 0.023 CID_7258 0.045 0.039 CID_11334 | CID_7258 | |
| 0.037 | 0.016 | 0.037 | Prostaglandin EP3 antagonist | |||
| 0.03 | 0.009 | 0.03 | Vanilloid 2 agonist | 0.029 0.01 CID_7258 0.027 0.014 CID_11334 | ||
| 0.055 | 0.034 | 0.055 | Histamine agonist | |||
| 0.063 | 0.042 | 0.063 | Histone deacetylase SIRT3 inhibitor | |||
| 0.035 | 0.015 | 0.035 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.055 | 0.035 | 0.055 | Toll-Like receptor 8 antagonist | |||
| 0.039 | 0.019 | 0.051 | RNA-directed RNA polymerase inhibitor | 0.051 0.012 CID_7258 0.048 0.014 CID_11334 | CID_7258 | |
| 0.025 | 0.005 | 0.041 | Nicotinic acid receptor 1 antagonist | 0.041 0.003 CID_7258 0.026 0.005 CID_11334 | CID_7258 | |
| 0.024 | 0.005 | 0.024 | CC chemokine 9 receptor antagonist | 0.017 0.012 CID_7258 0.016 0.014 CID_11334 | ||
| 0.024 | 0.005 | 0.024 | CXC chemokine 5 receptor antagonist | |||
| 0.029 | 0.01 | 0.029 | Geranylgeranyltransferase inhibitor | |||
| 0.036 | 0.017 | 0.036 | Dipeptidyl peptidase II inhibitor | |||
| 0.04 | 0.021 | 0.04 | Bradykinin antagonist | |||
| 0.111 | 0.092 | 0.111 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.04 | 0.021 | 0.04 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.041 | 0.022 | 0.041 | Leukotriene C4 antagonist | 0.04 0.024 CID_7258 0.04 0.025 CID_11334 | ||
| 0.133 | 0.115 | 0.238 | Dual specificity phosphatase inhibitor | 0.238 0.041 CID_7258 0.143 0.102 CID_11334 | CID_7258 | |
| 0.054 | 0.036 | 0.054 | Sphingosine 1-phosphate receptor 5 agonist | 0.05 0.047 CID_7258 | ||
| 0.033 | 0.015 | 0.033 | Thrombin receptor antagonist | |||
| 0.094 | 0.076 | 0.105 | Expectorant | 0.105 0.063 CID_7258 0.092 0.078 CID_11334 | CID_7258 | |
| 0.056 | 0.039 | 0.056 | Carbonic anhydrase IX inhibitor | |||
| 0.041 | 0.023 | 0.041 | MAP3K5 inhibitor | |||
| 0.056 | 0.038 | 0.056 | MAP kinase kinase 9 inhibitor | |||
| 0.054 | 0.037 | 0.054 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.039 | 0.022 | 0.039 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.043 | 0.026 | 0.043 | Glutamate (mGluR1a) antagonist | |||
| 0.054 | 0.037 | 0.054 | Lysine-specific demethylase 1A inhibitor | |||
| 0.038 | 0.021 | 0.038 | Glutamate (mGluR8) antagonist | |||
| 0.12 | 0.103 | 0.259 | Farnesoid X receptor antagonist | 0.259 0.01 CID_7258 0.135 0.074 CID_11334 | CID_7258 | |
| 0.03 | 0.013 | 0.047 | Dopamine autoreceptor agonist | 0.047 0.008 CID_7258 | CID_7258 | |
| 0.03 | 0.014 | 0.03 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.051 | 0.035 | 0.051 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.028 | 0.012 | 0.028 | Glutamate (mGluR1) agonist | 0.023 0.02 CID_11334 | ||
| 0.045 | 0.029 | 0.045 | AICAR transformylase inhibitor | 0.041 0.036 CID_7258 | ||
| 0.079 | 0.063 | 0.079 | I kappa B kinase inhibitor | |||
| 0.065 | 0.049 | 0.065 | CDC7 inhibitor | |||
| 0.055 | 0.039 | 0.055 | Carbonic anhydrase I inhibitor | |||
| 0.092 | 0.076 | 0.092 | Gastric antisecretory | |||
| 0.055 | 0.04 | 0.075 | Beta 1 adrenoreceptor antagonist | 0.075 0.021 CID_7258 0.052 0.044 CID_11334 | CID_7258 | |
| 0.059 | 0.044 | 0.059 | Potassium channel (Ca-activated) blocker | |||
| 0.017 | 0.002 | 0.017 | DNA polymerase III subunit alpha inhibitor | 0.008 0.004 CID_7258 0.007 0.005 CID_11334 | ||
| 0.034 | 0.019 | 0.034 | Vanilloid 4 antagonist | |||
| 0.045 | 0.031 | 0.045 | Purinergic P2Y antagonist | |||
| 0.061 | 0.046 | 0.061 | Phosphodiesterase VII inhibitor | |||
| 0.019 | 0.004 | 0.019 | Thromboxane agonist | 0.019 0.004 CID_7258 0.014 0.005 CID_11334 | ||
| 0.017 | 0.002 | 0.017 | DNA topoisomerase III inhibitor | 0.01 0.004 CID_7258 0.01 0.004 CID_11334 | ||
| 0.018 | 0.004 | 0.018 | Progesterone receptor A antagonist | 0.011 0.005 CID_7258 0.011 0.005 CID_11334 | ||
| 0.089 | 0.074 | 0.158 | Xanthine oxidase inhibitor | 0.158 0.032 CID_7258 0.094 0.065 CID_11334 | CID_7258 | |
| 0.021 | 0.006 | 0.021 | NMDA receptor phencyclidine site antagonist | 0.019 0.008 CID_7258 0.015 0.012 CID_11334 | ||
| 0.035 | 0.02 | 0.035 | Calcium release-activated channel blocker | |||
| 0.07 | 0.056 | 0.07 | Vanilloid antagonist | |||
| 0.093 | 0.078 | 0.1 | Mediator release inhibitor | 0.095 0.076 CID_7258 0.1 0.07 CID_11334 | CID_11334 | |
| 0.101 | 0.087 | 0.106 | Alkylator | 0.106 0.082 CID_7258 0.098 0.09 CID_11334 | CID_7258 | |
| 0.022 | 0.008 | 0.022 | Glucagon agonist | |||
| 0.021 | 0.007 | 0.021 | Nicotinic alpha4 receptor agonist | |||
| 0.025 | 0.011 | 0.025 | Prostaglandin EP1 antagonist | |||
| 0.02 | 0.007 | 0.02 | Prokineticin receptor 1 antagonist | |||
| 0.028 | 0.015 | 0.028 | Calcium-sensing receptor agonist | |||
| 0.021 | 0.008 | 0.021 | Carbonic anhydrase VIII inhibitor | |||
| 0.021 | 0.008 | 0.021 | Carbonic anhydrase X inhibitor | |||
| 0.057 | 0.044 | 0.057 | Carbonic anhydrase stimulant | |||
| 0.027 | 0.014 | 0.027 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.027 | 0.014 | 0.034 | Prostaglandin EP2 agonist | 0.034 0.011 CID_7258 0.027 0.013 CID_11334 | CID_7258 | |
| 0.018 | 0.005 | 0.018 | Carbonic anhydrase XI inhibitor | |||
| 0.056 | 0.043 | 0.056 | Cathepsin L inhibitor | |||
| 0.029 | 0.017 | 0.029 | Sigma 2 receptor antagonist | |||
| 0.029 | 0.017 | 0.029 | Lysine carboxypeptidase inhibitor | 0.025 0.02 CID_7258 | ||
| 0.038 | 0.026 | 0.038 | Melanocortin 1 antagonist | |||
| 0.053 | 0.041 | 0.058 | Carbonic anhydrase II inhibitor | 0.058 0.037 CID_11334 | CID_11334 | |
| 0.059 | 0.047 | 0.068 | Carbonic anhydrase inhibitor | 0.068 0.041 CID_11334 | CID_11334 | |
| 0.039 | 0.027 | 0.039 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.041 | 0.029 | 0.041 | CDK5/p25 inhibitor | 0.037 0.034 CID_7258 0.036 0.035 CID_11334 | ||
| 0.079 | 0.067 | 0.079 | Acetylcholine agonist | |||
| 0.068 | 0.056 | 0.072 | Dopamine antagonist | 0.072 0.052 CID_11334 | CID_11334 | |
| 0.062 | 0.051 | 0.088 | Beta adrenoreceptor antagonist | 0.088 0.022 CID_7258 0.072 0.035 CID_11334 | CID_7258 | |
| 0.017 | 0.005 | 0.017 | Integrin beta2 antagonist | |||
| 0.027 | 0.016 | 0.053 | Thyroid hormone agonist | 0.053 0.004 CID_7258 0.031 0.011 CID_11334 | CID_7258 | |
| 0.025 | 0.013 | 0.025 | Urotensin II antagonist | |||
| 0.032 | 0.02 | 0.038 | Prostaglandin agonist | 0.038 0.015 CID_7258 0.03 0.022 CID_11334 | CID_7258 | |
| 0.019 | 0.008 | 0.019 | Telomerase stimulant | 0.019 0.009 CID_7258 0.018 0.01 CID_11334 | ||
| 0.054 | 0.044 | 0.054 | Alpha 1 adrenoreceptor agonist | |||
| 0.022 | 0.011 | 0.022 | Factor XIII inhibitor | |||
| 0.042 | 0.031 | 0.042 | Acetylcholine M1 receptor agonist | |||
| 0.039 | 0.028 | 0.039 | Cathepsin L1 inhibitor | |||
| 0.022 | 0.012 | 0.022 | Retinoid X beta receptor antagonist | |||
| 0.04 | 0.03 | 0.04 | Acid-sensing ion channel blocker | |||
| 0.019 | 0.01 | 0.019 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.034 | 0.025 | 0.034 | Retinoid X alpha receptor agonist | |||
| 0.025 | 0.015 | 0.025 | 5 Hydroxytryptamine 4 agonist | |||
| 0.044 | 0.035 | 0.069 | Glycine transporter 2 inhibitor | 0.069 0.021 CID_7258 | CID_7258 | |
| 0.02 | 0.011 | 0.02 | Histamine H4 receptor agonist | |||
| 0.031 | 0.022 | 0.042 | HCV NS5B polymerase inhibitor | 0.042 0.013 CID_7258 0.038 0.016 CID_11334 | CID_7258 | |
| 0.015 | 0.006 | 0.015 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.113 | 0.105 | 0.113 | Activin receptor-like kinase 2 inhibitor | |||
| 0.039 | 0.032 | 0.106 | Estradiol 17 beta-dehydrogenase inhibitor | 0.106 0.01 CID_7258 0.087 0.012 CID_11334 | CID_7258 | |
| 0.055 | 0.047 | 0.055 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.048 | 0.04 | 0.048 | Carbonic anhydrase XII inhibitor | |||
| 0.029 | 0.022 | 0.029 | Peptide deformylase inhibitor | |||
| 0.018 | 0.011 | 0.018 | G-protein-coupled receptor 120 agonist | 0.016 0.013 CID_7258 0.017 0.012 CID_11334 | ||
| 0.012 | 0.005 | 0.012 | Corticotropin releasing factor antagonist | |||
| 0.04 | 0.033 | 0.04 | Sphingosine 1-phosphate receptor 1 agonist | 0.04 0.032 CID_7258 0.038 0.036 CID_11334 | ||
| 0.077 | 0.07 | 0.077 | GABA A receptor agonist | |||
| 0.016 | 0.01 | 0.016 | Purinergic P2Y1 agonist | 0.015 0.012 CID_7258 | ||
| 0.033 | 0.026 | 0.033 | Angiotensin II receptor antagonist | |||
| 0.047 | 0.041 | 0.064 | Beta 2 adrenoreceptor antagonist | 0.064 0.021 CID_7258 0.058 0.026 CID_11334 | CID_7258 | |
| 0.018 | 0.012 | 0.018 | Potassium channel (Inward rectifier) 11 blocker | |||
| 0.019 | 0.013 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.009 CID_7258 0.02 0.011 CID_11334 | CID_7258 | |
| 0.077 | 0.071 | 0.077 | Histamine H2 receptor antagonist | |||
| 0.052 | 0.046 | 0.052 | Adenosine A1 receptor antagonist | |||
| 0.087 | 0.081 | 0.087 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.013 | 0.007 | 0.014 | Glutamate (mGluR6) agonist | 0.012 0.008 CID_7258 0.014 0.006 CID_11334 | CID_11334 | |
| 0.014 | 0.009 | 0.014 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.023 | 0.017 | 0.027 | Prostaglandin E2 agonist | 0.027 0.013 CID_7258 0.022 0.018 CID_11334 | CID_7258 | |
| 0.031 | 0.025 | 0.031 | GHS receptor antagonist | |||
| 0.041 | 0.036 | 0.041 | Sphingosine 1-phosphate receptor agonist | 0.041 0.036 CID_7258 | ||
| 0.042 | 0.037 | 0.042 | Dipeptidyl peptidase IV inhibitor | |||
| 0.037 | 0.032 | 0.037 | Histone deacetylase 9 inhibitor | |||
| 0.009 | 0.005 | 0.009 | Free fatty acid receptor 2 antagonist | |||
| 0.011 | 0.007 | 0.011 | Imidazoline I2 receptor antagonist | |||
| 0.035 | 0.031 | 0.035 | Retinoid X receptor antagonist | |||
| 0.025 | 0.021 | 0.025 | Urotensin II agonist | |||
| 0.087 | 0.083 | 0.087 | Insulin receptor antagonist | |||
| 0.017 | 0.013 | 0.017 | Sodium/hydrogen exchanger inhibitor | |||
| 0.033 | 0.03 | 0.033 | Histone deacetylase 7 inhibitor | |||
| 0.038 | 0.035 | 0.038 | VCAM antagonist | 0.038 0.031 CID_7258 | ||
| 0.038 | 0.035 | 0.038 | VCAM-1 antagonist | 0.038 0.031 CID_7258 | ||
| 0.026 | 0.023 | 0.026 | Glucosylceramidase stimulant | |||
| 0.045 | 0.042 | 0.045 | HCV NS3/NS4A protease inhibitor | |||
| 0.012 | 0.009 | 0.012 | Egl nine homolog 3 inhibitor | 0.011 0.009 CID_7258 | ||
| 0.057 | 0.055 | 0.062 | Leukotriene antagonist | 0.062 0.048 CID_7258 | CID_7258 | |
| 0.032 | 0.029 | 0.032 | Retinoid X alpha receptor antagonist | |||
| 0.019 | 0.017 | 0.019 | Adenosine kinase inhibitor | |||
| 0.013 | 0.011 | 0.013 | Prostaglandin EP4 agonist | |||
| 0.006 | 0.004 | 0.006 | CC chemokine 6 receptor agonist | |||
| 0.042 | 0.04 | 0.042 | Glutamate (mGluR5) antagonist | |||
| 0.116 | 0.115 | 0.116 | Aurora-C kinase inhibitor | |||
| 0.12 | 0.119 | 0.12 | CDC-like kinase 2 inhibitor | |||
| 0.011 | 0.01 | 0.011 | Thrombopoietin agonist | |||
| 0.023 | 0.022 | 0.023 | Prostaglandin EP4 antagonist | |||
| 0.073 | 0.072 | 0.073 | Neuropeptide Y antagonist | |||
| 0.011 | 0.01 | 0.011 | Purine nucleoside phosphorylase inhibitor | |||
| 0.043 | 0.042 | 0.051 | Beta adrenoreceptor agonist | 0.051 0.016 CID_7258 0.048 0.021 CID_11334 | CID_7258 | |
| 0.033 | 0.032 | 0.033 | Factor XIIIa inhibitor | |||
| 0.033 | 0.032 | 0.033 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.051 | 0.052 | 0.089 | Adenine nucleotide translocase inhibitor | 0.089 0.006 CID_7258 0.07 0.015 CID_11334 | CID_7258 | |
| 0.065 | 0.066 | 0.084 | CDC25A inhibitor | 0.084 0.039 CID_7258 0.074 0.051 CID_11334 | CID_7258 | |
| 0.016 | 0.02 | 0.026 | Estrogen-related receptor gamma agonist | 0.026 0.005 CID_7258 0.019 0.013 CID_11334 | CID_7258 | |
| 0.052 | 0.056 | 0.058 | Dopamine D2 antagonist | 0.058 0.051 CID_11334 | CID_11334 | |
| 0.017 | 0.021 | 0.022 | Aggrecanase 2 inhibitor | 0.022 0.015 CID_7258 | CID_7258 | |
| 0.019 | 0.024 | 0.025 | Beta 1 adrenoreceptor agonist | 0.025 0.013 CID_7258 | CID_7258 | |
| 0.006 | 0.012 | 0.016 | Thyroid hormone beta agonist | 0.016 0.004 CID_7258 | CID_7258 | |
| 0.041 | 0.049 | 0.118 | Aldose reductase inhibitor | 0.118 0.014 CID_7258 0.078 0.024 CID_11334 | CID_7258 | |
| 0.044 | 0.052 | 0.074 | Xanthine dehydrogenase inhibitor | 0.074 0.028 CID_7258 0.067 0.033 CID_11334 | CID_7258 | |
| 0.004 | 0.012 | 0.008 | Insulin like growth factor 3 antagonist | 0.008 0.004 CID_7258 0.008 0.004 CID_11334 | CID_11334 | |
| 0.081 | 0.09 | 0.154 | Monophenol monooxygenase inhibitor | 0.154 0.045 CID_7258 0.109 0.07 CID_11334 | CID_7258 | |
| 0.01 | 0.02 | 0.014 | Egl nine homolog 1 inhibitor | 0.014 0.011 CID_7258 | CID_7258 | |
| 0.015 | 0.025 | 0.048 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.048 0.007 CID_7258 0.039 0.009 CID_11334 | CID_7258 | |
| 0.053 | 0.064 | 0.187 | CDC25B inhibitor | 0.072 0.036 CID_7258 0.187 0.005 CID_11334 | CID_11334 | |
| 0.085 | 0.1 | 0.131 | Toll-Like receptor 4 antagonist | 0.131 0.034 CID_7258 0.095 0.078 CID_11334 | CID_7258 | |
| 0.177 | 0.193 | 0.233 | Thioredoxin glutathione reductase inhibitor | 0.233 0.146 CID_11334 | CID_11334 | |
| 0.022 | 0.039 | 0.032 | Liver X receptor alpha antagonist | 0.032 0.016 CID_7258 0.028 0.023 CID_11334 | CID_7258 | |
| 0.045 | 0.063 | 0.053 | Acetylcholine M3 receptor antagonist | 0.053 0.051 CID_7258 | CID_7258 | |
| 0.06 | 0.08 | 0.122 | Analgesic, opioid | 0.122 0.022 CID_7258 | CID_7258 | |
| 0.114 | 0.137 | 0.121 | Death-associated protein kinase 1 inhibitor | 0.121 0.11 CID_7258 | CID_7258 | |
| 0.019 | 0.045 | 0.029 | Liver X receptor antagonist | 0.029 0.023 CID_7258 | CID_7258 | |
| 0.025 | 0.053 | 0.071 | Dopamine D5 antagonist | 0.039 0.033 CID_7258 0.071 0.014 CID_11334 | CID_11334 | |
| 0.121 | 0.149 | 0.358 | Interleukin antagonist | 0.233 0.068 CID_7258 0.358 0.037 CID_11334 | CID_11334 | |
| 0.063 | 0.092 | 0.151 | Opioid kappa receptor antagonist | 0.151 0.017 CID_7258 0.089 0.046 CID_11334 | CID_7258 | |
| 0.025 | 0.062 | 0.035 | Erythropoietin receptor agonist | 0.035 0.034 CID_7258 | CID_7258 | |
| 0.023 | 0.062 | 0.072 | Estrogen-related receptor beta antagonist | 0.072 0.004 CID_7258 0.044 0.008 CID_11334 | CID_7258 | |
| 0.01 | 0.05 | 0.026 | Thyroid hormone alpha agonist | 0.026 0.004 CID_7258 | CID_7258 | |
| 0.051 | 0.092 | 0.137 | Topoisomerase II alpha inhibitor | 0.137 0.026 CID_7258 0.068 0.063 CID_11334 | CID_7258 | |
| 0.051 | 0.103 | 0.118 | HIV-1 integrase inhibitor | 0.118 0.016 CID_7258 0.096 0.027 CID_11334 | CID_7258 | |
| 0.02 | 0.088 | 0.033 | Peroxisome proliferator-activated receptor delta antagonist | 0.033 0.023 CID_7258 | CID_7258 | |
| 0.012 | 0.087 | 0.14 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.127 0.004 CID_7258 0.14 0.004 CID_11334 | CID_11334 | |
| 0.064 | 0.139 | 0.117 | c-Src kinase inhibitor | 0.117 0.077 CID_11334 | CID_11334 | |
| 0.022 | 0.106 | 0.062 | Opioid agonist | 0.062 0.028 CID_7258 | CID_7258 | |
| 0.086 | 0.175 | 0.172 | Protein-tyrosine phosphatase inhibitor | 0.172 0.061 CID_7258 0.147 0.081 CID_11334 | CID_7258 | |
| 0.072 | 0.164 | 0.102 | M17 leucyl aminopeptidase inhibitor | 0.102 0.098 CID_7258 | CID_7258 | |
| 0.005 | 0.103 | 0.291 | Estrogen receptor alpha agonist | 0.291 0.004 CID_7258 0.093 0.01 CID_11334 | CID_7258 | |
| 0.049 | 0.152 | 0.18 | 5-Lipoxygenase inhibitor | 0.18 0.029 CID_7258 0.093 0.069 CID_11334 | CID_7258 | |
| 0.014 | 0.12 | 0.043 | Estrogen-related receptor alpha antagonist | 0.043 0.016 CID_7258 | CID_7258 | |
| 0.057 | 0.171 | 0.413 | Estrogen receptor beta antagonist | 0.413 0.004 CID_7258 0.31 0.005 CID_11334 | CID_7258 | |
| 0.005 | 0.138 | 0.017 | Thyroid hormone alpha antagonist | 0.017 0.01 CID_7258 0.015 0.012 CID_11334 | CID_7258 | |
| 0.027 | 0.16 | 0.069 | Leukotriene synthesis inhibitor | 0.063 0.051 CID_7258 0.069 0.045 CID_11334 | CID_11334 | |
| 0.011 | 0.145 | 0.052 | Catechol O-methyltransferase inhibitor | 0.052 0.008 CID_7258 0.034 0.021 CID_11334 | CID_7258 | |
| 0.06 | 0.194 | 0.08 | 3C-Like protease (SARS coronavirus) inhibitor | 0.08 0.069 CID_7258 | CID_7258 | |
| 0.127 | 0.276 | 0.217 | Peptidyltransferase inhibitor | 0.217 0.079 CID_7258 0.179 0.13 CID_11334 | CID_7258 | |
| 0.063 | 0.212 | 0.413 | Estrogen antagonist | 0.413 0.004 CID_7258 0.386 0.005 CID_11334 | CID_7258 | |
| 0.084 | 0.233 | 0.144 | Dyrk kinase inhibitor | 0.144 0.142 CID_7258 | CID_7258 | |
| 0.038 | 0.192 | 0.135 | Opioid antagonist | 0.135 0.03 CID_7258 | CID_7258 | |
| 0.015 | 0.172 | 0.075 | Alpha tubulin antagonist | 0.075 0.021 CID_7258 | CID_7258 | |
| 0.075 | 0.236 | 0.156 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.156 0.126 CID_7258 0.152 0.129 CID_11334 | CID_7258 | |
| 0.011 | 0.172 | 0.072 | Beta tubulin antagonist | 0.072 0.033 CID_7258 | CID_7258 | |
| 0.053 | 0.218 | 0.137 | Bone formation stimulant | 0.137 0.07 CID_7258 | CID_7258 | |
| 0.004 | 0.177 | 0.265 | Estrogen receptor beta agonist | 0.265 0.004 CID_7258 0.141 0.008 CID_11334 | CID_7258 | |
| 0.142 | 0.321 | 0.256 | Interleukin 2 agonist | 0.256 0.113 CID_7258 0.208 0.176 CID_11334 | CID_7258 | |
| 0.134 | 0.314 | 0.279 | Apoptosis antagonist | 0.232 0.146 CID_7258 0.279 0.101 CID_11334 | CID_11334 | |
| 0.052 | 0.234 | 0.097 | Nav1.4 sodium channel blocker | 0.097 0.081 CID_7258 | CID_7258 | |
| 0.016 | 0.202 | 0.079 | HIV-1 integrase (Strand Transfer) inhibitor | 0.079 0.031 CID_7258 | CID_7258 | |
| 0.018 | 0.208 | 0.039 | GHS receptor agonist | 0.039 0.037 CID_11334 | CID_11334 | |
| 0.019 | 0.213 | 0.098 | HIV-1 integrase (3'-Processing) inhibitor | 0.098 0.027 CID_7258 0.063 0.045 CID_11334 | CID_7258 | |
| 0.006 | 0.226 | 0.025 | Dopamine D1 agonist | 0.025 0.013 CID_7258 0.022 0.017 CID_11334 | CID_7258 | |
| 0.037 | 0.259 | 0.184 | Uric acid excretion stimulant | 0.096 0.056 CID_7258 0.184 0.015 CID_11334 | CID_11334 | |
| 0.007 | 0.248 | 0.316 | Estrogen agonist | 0.316 0.005 CID_7258 0.12 0.014 CID_11334 | CID_7258 | |
| 0.046 | 0.292 | 0.091 | Vanilloid agonist | 0.091 0.046 CID_7258 0.09 0.048 CID_11334 | CID_7258 | |
| 0.011 | 0.29 | 0.093 | Opioid mu receptor antagonist | 0.093 0.034 CID_7258 | CID_7258 | |
| 0.015 | 0.299 | 0.118 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.118 0.027 CID_11334 | CID_11334 | |
| 0.009 | 0.309 | 0.089 | Opioid delta receptor antagonist | 0.089 0.033 CID_7258 | CID_7258 | |
| 0.12 | 0.426 | 0.322 | Cyclophilin D inhibitor | 0.322 0.144 CID_7258 | CID_7258 | |
| 0.077 | 0.385 | 0.392 | Immunosuppressant | 0.392 0.067 CID_11334 | CID_11334 | |
| 0.073 | 0.394 | 0.255 | Hypoglycemic | 0.255 0.074 CID_7258 | CID_7258 | |
| 0.044 | 0.394 | 0.22 | Interleukin 4 antagonist | 0.22 0.018 CID_7258 0.165 0.038 CID_11334 | CID_7258 | |
| 0.02 | 0.413 | 0.119 | Topoisomerase II inhibitor | 0.119 0.068 CID_7258 | CID_7258 | |
| 0.092 | 0.495 | 0.295 | Apoptosis agonist | 0.295 0.176 CID_7258 0.283 0.184 CID_11334 | CID_7258 | |
| 0.031 | 0.434 | 0.105 | DNA polymerase I inhibitor | 0.105 0.08 CID_7258 | CID_7258 | |
| 0.005 | 0.422 | 0.043 | Opioid mu receptor agonist | 0.043 0.036 CID_7258 | CID_7258 | |
| 0.039 | 0.457 | 0.148 | Platelet adhesion inhibitor | 0.148 0.108 CID_7258 | CID_7258 | |
| 0.022 | 0.446 | 0.138 | Chelator | 0.138 0.04 CID_7258 | CID_7258 | |
| 0.004 | 0.44 | 0.046 | Sphingosine 1-phosphate receptor 3 agonist | 0.046 0.018 CID_11334 | CID_11334 | |
| 0.061 | 0.502 | 0.142 | MAP kinase kinase 4 inhibitor | 0.142 0.08 CID_7258 | CID_7258 | |
| 0.04 | 0.492 | 0.087 | Interleukin 12 antagonist | 0.087 0.079 CID_7258 | CID_7258 | |
| 0.035 | 0.5 | 0.168 | Nitric oxide antagonist | 0.168 0.083 CID_7258 | CID_7258 | |
| 0.028 | 0.514 | 0.196 | Amyloid beta aggregation inhibitor | 0.196 0.08 CID_7258 | CID_7258 | |
| 0.026 | 0.518 | 0.362 | Free radical scavenger | 0.362 0.036 CID_7258 0.186 0.11 CID_11334 | CID_7258 | |
| 0.083 | 0.577 | 0.303 | Antiinflammatory | 0.303 0.212 CID_7258 | CID_7258 | |
| 0.04 | 0.543 | 0.155 | Hepatoprotectant | 0.155 0.105 CID_7258 | CID_7258 | |
| 0.099 | 0.625 | 0.358 | Calcium channel L-type activator | 0.358 0.111 CID_7258 0.231 0.228 CID_11334 | CID_7258 | |
| 0.029 | 0.599 | 0.087 | Transcription factor NF kappa B stimulant | 0.087 0.056 CID_7258 | CID_7258 | |
| 0.018 | 0.649 | 0.328 | Antioxidant | 0.328 0.052 CID_7258 0.203 0.111 CID_11334 | CID_7258 | |
| 0.05 | 0.728 | 0.116 | Papain-like protease (SARS coronavirus) inhibitor | 0.116 0.093 CID_7258 | CID_7258 | |
| 0.005 | 0.828 | 0.149 | Lipid peroxidase inhibitor | 0.149 0.069 CID_7258 | CID_7258 | |
| 0.017 | 0.967 | 0.235 | Sodium/bile acid cotransporter inhibitor | 0.235 0.145 CID_7258 | CID_7258 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |